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SLE systemic lupus erythematosus
SUMMARY
Polymorphonuclear leucocytes and monocytes play an important 
role in the inflammatory response. The ability of these cell types 
to degranulate in response to particulate aggregated IgGl was 
studied after their isolation from the peripheral blood of two 
groups of people. These consisted of patients suffering from the 
chronic inflammatory disease Rheumatoid Arthritis, and, for 
comparison, a number of apparently healthy, normal controls.
The patients' neutrophils manifest a lower responsiveness than 
normals in this system, while the monocytes behaved similarly 
in both groups. The membrane-mediated "metabolic burst" was 
measured directly by superoxide release and serum thiol oxidation; 
in neither of these was a significant difference found between 
normals and the patients, although patients' cells showed a 
trend towards a higher thiol-oxidising ability. ITius a 
degranulation or lysosomal defect is implicated.
The effect of the addition of rheumatoid factor to the 
incubation medium was studied. A preparation which consisted 
of both IgM and IgG anti-IgG (MxRF) was found to inhibit 
degranulation by monocytes, while pure IgM RF had no such effect.
A similar,though less marked, inhibition could alternatively 
be induced by adding soluble aggregates of IgGl to the degranul­
ation-inducing system. The implications of this are discussed.
The soluble aggregates and the MxRF, whilst not causing degranu­
lation, were able to stimulate neutrophils and monocytes to 
release oxygen radicals. This confirms previous observations 
of the independence of the two reactions.
CHAPTER 1. INTRODUCTION
In a progression of experiments from 1882 to the opening years 
of the twentieth century, the now-famous scientist Elie Metchnikoff 
showed an awareness of the importance, of phagocytes in inflammatory 
responses (1883, 1938). He was able to distinguish between micro­
phages and macrophages and noted that the former preceded the 
latter in moving into a site of inflammation. The aim of this 
introduction is to put forward some modern knowledge about these 
cells and relate it to their role in acute and chronic inflammation.
Mononuclear phagocytes
It is now realised that the macrophages that accumulate in 
inflammatory areas are of monocyte origin, and these two cell types 
form the major part of what is now termed the mononuclear phagocyte 
system (van Furth, Raeburn and van Zwet, 1979). The bone marrow 
monoblasts and promonocytes, which can divide, are also included.
The peripheral blood monocyte is derived from these precursors 
and has an apparent half-life of seventy-one hours in the circulation, 
It has a diameter of about 14 ym and staining with Romanovsky dyes 
reveals a large blue-grey, horseshoe shaped, nucleus against a pale 
grey cytoplasm in which no granules can be distinguished. Vacuoles 
can be present. Figure la illustrates the typical appearance seen 
in a smear of peripheral blood. The cell is peroxidase and non­
specific esterase positive (Yam, 1971),and both properties are 
useful in its resolution from the smaller, non-phagocytic, lymphocyte, 
Following its circulation, the monocyte migrates to a tissue site 
to develop into a macrophage, which has a smaller, rounded and
purple-staining nucleus and a large amount of blue cytoplasm in 
which vacuoles are present.(see Figure lb, which shows a number 
of alveolar macrophages harvested by broncholavage). The cell 
diameter is about 20 ym.
The mononuclear phagocyte possesses an extensive lysosomal 
system and secretory capacity (Nathan,Murray and Cohn, 1980).
Since the circulating monocyte is relatively non-activated, it 
contains fewer enzymes than its tissue counterpart (Bennet and 
Cohn, 1974), and has a higher nuclear:cytoplasmic ratio. The level 
of lysosomal enzymes differs amongst macrophages, and tends to 
show a positive correlation with their activated state (Cohn, 1978), 
although sane cultured macrophages appear to lose their peroxidatic 
activity (van der Meer et ai., 1979). One function of this 
armamentarium is to inactivate or kill ingested particles within 
the protective membrane of a phagosome. The products that macro­
phages can be induced to secrete into the environment include 
neutral proteases such as plasminogen activator (PA), elastase 
and collagenase; complement components; enzyme inhibitors and 
chemotactic factors (Davies et ai., 1977; Steinman and Cohn,
1974). PA promotes activation of the fibrinolytic system, 
while collagenase influencescollagen deposition in the extra­
cellular space, and elastase can create chemotactic fragments 
from the complement 'component C5 (Ward, 197 9).
In addition to their role as secretory cells, macrophages 
are important in immune responses; effective antigen presentation 
at the macrophage surface is a requirement for most lymphocyte 
responses to antigen (McConnell, 1976b), whether for the production
ê
a om
t  #  . A T
Fi/Ture la.
Peripheral blood monocyte from normal control. x6?0
#
Figure 1b.
Alveolar macrophages, obtained at bronchoscopy with 
lavage. To be noted are the binucleate cells and the 
relative size of macrophage and monocyte (see Figure la) 
From a patient with scleroderma, x 630
Figure 1c.
i eripheral blood neutrophil. ,_____ , represents
size of a monocyte for comparison (Figure la). 
Each erythrocyte is approximately 7 jun.
From a normal control, x 63O
of antibodies or for cell-mediated immunity (Nelson, 1981). The 
intercalation of tliese diverse properties has been stressed in, 
for instance, the host response to herpes simplex virus, as has 
been reviewed by Morahan and Morse (197 9) .
Surface receptors on mononuclear phagocytes.
Human monocytes express receptors for the Fc portion of 
IgGl and IgG3 (Huber and Fudenberg, 1968), but only weakly for 
IgG2. They also have receptors for IgM and for the complement 
component fraction C3b(Ehlenberger and Nussenweig, 1977).
Although they were thought to possess C3d receptors (Ehlenberger 
and Nussenweig, 1977), it now seems likely that this was confused 
with the C3b' receptor, as discussed by Scott (1931). These 
recognition sites enable the cells to bind and phagocytose opson­
ized particles. The immunoglobulin receptors may also be impor­
tant in the role of monocytes as accessory cells in T-B lymphocyte 
cooperation (Roitt, 1977).
Polymorphonuclear leucocytes.
In contrast to the bimodal behaviour of the macrophages, the 
cells that Metchnikoff called microphages are solely phagocytic. 
These are now termed granulocytes or polymorphonuclear leucocytes 
(PMN) because of the granules and multi-lobed nucleus discernable 
after fixation and staining with Romanovsky dyes (see Figure Ic). 
There are three populations of these bone marrow derived cells 
which, in man, are neutrophilic (about 95%), eosinophilic (4%) 
and basophilic (1%). It is the neutrophils which are employed 
in host defence against bacterial invasion, and play a large part
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in inflammatory responses, be they mediated by infection or by 
tissue damage. Eosinophils are prominent in counteracting para­
sitic infection (Glauert et al., 1978), and basophils are probably 
precursors of mast cells.
The neutrophils are smaller than monocytes (approximately 
10 ym in diameter), and this can be seen if comparison is made 
between Figures la and Ic; an erythrocyte is about 7 ym across.
The cytoplasm stains faintly pink owing to the presence of a large 
number of granules. The migrating cell is not round; when allowed 
to move over a glass slide its shape changes constantly, with a 
broad pseudopod proceeding a region containing the nucleus and 
granules, and a smaller, trailing portion. Its adhesive properties 
and ease of motility (Zigmond, 1978) are indicative of the 
fvinction of the cell; that is, to stick to and proceed through 
the capillary endothelium to the tissues in response to chemo­
tactic factors. In contrast to the monocyte, the neutrophil 
does not apparently marginate in the absence of a stimulus, nor 
does it mature once in the tissues. Its lifetime is about ten hours 
in the blood and up to two days in the extra-vascular regions, 
though 3 - 4  hours seems the modal lifespan (Bainton, Ullyot and 
Farquar, 1971; Hirsch, 1974), The fate of the effete cells 
in the blood is unknown.
The granules from various species have been characterized 
as membrane-bound vesicles which develop during the maturation 
of the granulocyte in the bone marrow. In humans they have been 
resolved into azurophil and specific granules; the former contain
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all the cellular myeloperoxidase, the acid hydrolases and part 
of the lysozyme, and the latter contain the remainder of the 
lysozyme and lactoferrin. Alkaline phosphatase and an acid 
phosphatase were found to be associated with a membranous rather 
than a granular fraction (Bretz and Baggiolini, 1974), More 
recent work by Segal and his colleagues has suggested that the 
peroxidase and acid hydrolases are located within different lyso- 
somes (Segal, Dorling and Coade, 1980). The granules as a 
whole contain proteases, carbohydrases, lipases, oxidases and 
enzymes able to cleave phosphates, sulphates and nucleic acids. 
Other constituents include lactoferrin and cationic proteins. 
(Hirsch, 1974; Oseas et al., 1981). Cytochemically, neutrophils 
stain very strongly for peroxidase and for an esterase that is 
distinct from the monocytic enzyme (Yam, 1971; van Furth, Raeburn 
and van Zwet, 1979).
Both polymorphonuclear and mononuclear phagocytes have a 
bactericidal capacity which is dependent on the generation of 
highly reactive oxygen metabolites in response to the stimulus.
The superoxide (O^") forming enzyme which may initiate the reaction 
(NAD(P)H-dependent . generating enzyme) is membrane-bound and 
appears to be associated with the plasma membrane rather than 
with specific or azurophil granules (Dewald et al., 1979), as 
are the active serine proteases that appear to be necessary for 
initiation and maintenance of the response (Kitagawa, Takaku and 
Sakamoto, 1980a) . Experiments conducted by McPhail (McPhail,
Henson and Johnston, 1981) suggest tliat the cell is switched 
on by multiple mechanisms. Evidence is in favour of the oxidase
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being a transmembrane protein with the reducing moiety on the cyto­
plasmic side (Babior et al., 1981); thus when the phagocytic 
vacuole is formed the interior contains the superoxide (and hydrogen 
peroxide) molecules while the cytoplasmic face supplies the hydrogen 
ions from an HMPS (hexose monophosphate shunt) that has also been 
activated as part of this coordinated set of events. Another 
enzyme, catalase ,can mediate the breakdown of hydrogen peroxide to 
water and oxygen, with two more active molecular species, singlet 
oxygen and hydroxyl radical, as intermediates (Weiss, King and 
LoBuglio, 1977; Rosen and Klebanoff, 1979). Myeloperoxidase 
(MPO) from lysosomes uses hydrogen peroxide and a halide in order 
to halogenate, and kill, bacteria (Klebanoff, 1975; Rosen and 
Klebanoff, 1979).
The characteristics of this burst of activity have been 
detailed by Klebanoff and co-workers (Klebanoff, 1975; Rosen and 
Klebanoff, 1976 and 1979), and are illustrated in Figure 1.2, which 
is based on a scheme proposed by Roos, Weening and Loos (1979).
These authors have stressed the importance of another peroxidase 
system (GSH-peroxidase/GSSG-reductase) which stimulates the HMPS 
when hydrogen peroxide is present, while detoxifying the latter by 
allowing it to oxidise the reduced glutathione (Roos, Weening 
and Loos, 1979). GSH and GSSG are the reduced and oxidised 
forms, respectively,'of the peptide glutathione.
Inherited enzyme deficiencies have helped to determine the 
relative importance of the reactions for bacterial killing, for 
instance in individuals suffering from catalase deficiency.and
Figure 1.2. Reactions involved in the generation of highly
reactive oxygen metabolites
Abbreviations employed:
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from chronic granulomatous disease (Klebanoff, 1975; Rosen and 
Klebanoff, 1975; Roos et al,, 1980). Acatalasémie individuals 
do not suffer from an increased incidence of infection, in contrast 
with which is the paucity of bacterial killing by CGD neutrophils 
through lack of activation of the membrane oxidase. Non-peroxide 
producing bacteria are the major source of infection in this 
disease (Roos et al., 1980; Baehner and Boxer, 1979).
The release of reactive oxygen species makes possible the 
reduction of nitroblue-tetrazolium (Wenger and Bole, 1973) and ferri- 
cytochrome C (Kitagawa, Takaku and Sakamoto, 1980a; Salin and 
McCord, 1974) and the excitation of lurninol and lucigenin (Easmon 
et al., 1980; Williams and Cole, 1981b) and these assays have been 
used to good effect to assess this release. The stimulation occurs 
similarly in both human granulocytes and monocytes (Sagone, King 
and Metz, 1976) and within one minute of exposure to the stimulus, 
if measured by chemiluminescence (Williams and Cole, 1981b), 
although the lag phase is more prolonged if cytochrome C is used 
as a detector (Rosen and Klebanoff, 1976). Malawista and Bodel's 
work in 1967 (Malawista and Bodel, 1967) showing that increased 
oxygen consumption could be dissociated from phagocytosis appear 
to have been confirmed by McPhail (McPhail, Henson and Johnston,
19 8L) and Williams and Cole (1981b) who have demonstrated 
by cytochrome C reduction and chemiluminescence, respectively, a 
response to the chemotactic peptide fMLP (f-Met-Leu-Phe) and other 
'soluble' compounds which do not promote a phagocytic event which 
leads to degranulation. These small molecules may induce 
pinocytosis and activation of the membrane signals.
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The peptide chemotactic factors do certainly activate a 
putative phagocytic mechanism because treatment of neutrophils 
with cytochalasin B reveals the secretogogue activity of the 
factors. Cytochalasin B is thought to act by disrupting micro­
filaments within the cell and allowing greater movement of 
granules. The larger protein chemotaxins do not need this 
fungal metabolite in order to stimulate release of enzymes from 
the cell into the environment (Wilkinson and Bradley, 1981), 
probably because they bind well to the substratum. Henson and 
his associates (Henson, Johnson and Spiegelberg, 1972) demonstrated 
that soluble immunoglobulin aggregates (both thermally and chemi­
cally induced) did not cause enzyme release from neutrophils in 
suspension, but did do so when bound to filters to form a non- 
phagocytosable surface; phagocytosis is a surface phenomenon 
since neutrophils crawl rather than swim (Henson, 1977). Exocytosis 
occurred in the fluid phase when similar, but insoluble, aggregates 
were incubated with neutrophils (see also Treadway et al., 1979). 
Both soluble and insoluble aggregates promoted HMPS stimulation.
The possible events in this differential lysosomal discharge are 
shown in Figure 1.3.
When human granulocytes are allowed to migrate, in a Boyden 
chamber, towards casein, they release a chymotrypsin-like cationic 
protein from their granules which has multiple effects on cell 
behaviour, especially on migration, aggregation and phagocytosis 
(Venge, 197 9; Bockenstedt and Goetzl, 1980). The same group of 
proteins was assigned a different role by Klebanoff (Klebanoff,
1975) who noted their antimicrobial activity, especially in the 
heterophiles from species (other than human) which do not contain
16
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myeloperoxidase; and yet another function in coagulation, by 
Goldstein (1974). These distinct properties need not be mutually 
exclusive since the compounds are themselves heterogenous (Olsson 
and Venge, 1974). Congenital defects in cationic proteins might 
clarify the situation but they are heterogeneous, and one has 
not yet been described (Klebanoff, 1975). Known deficiencies 
in lysosomal enzymes are not confined to the bactericidal 
failures mentioned above; the absence of any one of the acid 
hydrolases will result in the accumulation, within the phagocyte, 
of the substrate e.g. a mucopolysaccharide, to the detriment of 
and early death of the sufferer (Zurier,1979) . A primary 
defect may occur elsewhere in the cell, for instance in the 
Chediak-Higashi syndrome in which the microtubule assembly is 
aberrant (Zurier, 1979) : there is subnormal degranulation and 
bactericidal activity since the fusion of the phagosome and 
lysosomes is necessary for myeloperoxidase and/or cationic 
proteins to effect killing of an ingested organism, and for hydro­
lytic enzymes to subsequently degrade the foreign body.
Surface receptors on neutrophils.
Human neutrophils have receptors for all the IgG and IgA sub­
classes but these immunoglobulins bound to antigen may be relatively 
inefficient at promoting phagocytosis. They do not have receptors 
for IgM (Ehlenberger and Nussenweig, 1977). Binding of the 
complement component C3 to the antigen probably promotes contact 
between phagocyte and particle, but ingestion by neutrophils does 
not occur unless IgG, or IgA, is also present (Ehlenberger and 
Nussenweig, 1977; Henson, 1977). Both monocytes and neutrophils
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have receptors for C3b, but apparently not for C3d which is a 
breakdown product of the latter. Another biproduct, C3b', appears 
to be bound by neutrophils (Scott, C.S., 1981), and also by mono­
cytes (see a previous section). When another complement component 
is cleaved, the product C5a is a potent anaphylatoxin and highly 
chemotactic for neutrophils. Its physiological end-product,
C5a loses the former property while retaining the latter
(Henson, 1977; Chenoweth and Hugli, 1980) although to a lesser 
extent under some in vitro conditions (Perez et ai., 1980). Removal 
of more C-terminal amino acids abrogates this activity although 
it can still bind to the cell, which reinforces the principle 
that occupation of a receptor does not necessarily activate the 
phagocyte. Neutrophils also possess receptors for synthetic N- 
formylmethionyl peptides and for more natural compounds (Williams 
et ai., 1977; Spilberg and Mehta, 1979; Wilkinson and Bradley, 
1981).
Phagocytic cells; their role in inflammation
Insight into the cellular and chemical changes induced by acute 
inflammation has been gained using experimental systems such as the 
Reverse Passive Arthus reaction which is immune complex mediated 
and the reaction to carrageenan. These changes show marked simi­
larities although the exact kinetics may vary. The stimulus in vivo 
may be tissue injury, which would promote platelet clumping and 
release of serotonin (5-hydroxy-tryptamine), as well as activation 
of the coagulation cascade. It may be the presence of bacteria and 
the endotoxins that they can secrete (Gram positives only), (Ebert 
and Grant, 1974) which can damage leucocytes and also activate C3
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or cell fragments left after the replication and successful 
maturation of a lytic virus. Alternatively host antibody may 
complex with a foreign antigen and activate complement.
After the induction of an Arthus reaction, histamine and 5-HT 
release peak at one hour. These agents are among those that promote 
increased vascular permeability, which allows a leakage of fluid 
and proteins into the tissues which peaks at six hours. 
Contemporaneous with this is the maximum cumulative influx of 
granulocytes. Numbers of these cells decrease over forty-eight 
hours. The total number of mononuclear cells is found to be 
maximal at twelve hours, decreasing slowly thereafter (Dunn, Giroud 
and Willoughby, 1976).
Polymorph Emigration
Emigration of polymorphs from the blood vessel begins after 
about an hour. The leucocytes become 'sticky' and adhere to the 
capillary wall, resistant to the blood flowing past; they put 
out pseudopodia and squeeze through the enlarged endothelial 
junctions and penetrate the basement membrane, a process known 
as diapedesis (Ebert and Grant, 1974; Velo and Abdullahi, 1976). 
The emigration probably occurs in response to chemotactic 
factors generated by the stimulus, for instance C5a during the 
activation of complement by antigen-antibody complexes. It has 
been demonstrated that this chemotaxin and others such as the 
synthetic f-methionyl peptides and a bacterial factor from E. coli 
are capable of enhkncing the adhesiveness of granulocytes 
(O'Flaherty, Kreutzer and Ward, 1978; Smith et al., 1979) so that
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it is possible that they facilitate diapedesis, although conversely 
this adhesion could immobilize the cells (Fehr and Dahinden, 1979). 
Evidence that Clq, C3 and 04 can bind to vascular endothelium inde­
pendently of antibody has been advanced recently by Linder (Linder, 
1981), the tenet being that classical pathway activation of 
complement could occur during tissue injury without the need for 
the presence of antibody. This would tend to increase cellular 
adhesion; C5a and C3a would at the same time induce vasopermeability
When they have crossed the capillary wall, the granulocytes 
migrate through the tissues towards the site of insult, where they 
will phagocytose anything that promotes their binding and activation. 
The stimulants are likely to be surface-bound and this facilitates 
the job of these crawling phagocytes (Henson, 1977). Rabbit peri­
toneal neutrophils have been shown to require certain surfaces 
on which to adhere before they will degranulate in response to 
chemotactic factors (Becker et al., 1974).
As described earlier, the cells release their enzymes into 
phagolysosomes, and some will be discharged (through exocytosis) 
into the environment where they have varied actions including 
mediating tissue damage through proteolysis etc. Some granule 
constituents have been shown to increase the adherence of neutro­
phils and inhibit their chemotactic migration and to a lesser 
extent their random migration; (Bockenstedt and Goetzl, 1980); 
this would increase cellular accumulation. Lysozyme suppresses 
the chemotactic response (Becker et ai., 1974), but monocyte- 
derived lysozyme, at least, also depresses the oxidative mechanism
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of neutrophils (Gordon et al., 1979). The mononuclear phagocytes 
secrete this enzyme constitutively; since they migrate some hours 
after the granulocytes their product might modulate the ongoing 
response. The mechanism of these physiological reactions at the 
molecular level is incompletely understood, but membrane-protein 
alterations seem likely to be important in chemotaxis (Thrall et 
al., 1980)as do ionic changes (Seligmann and Gallin, 1980) and the 
relative levels of cAMP and cGMP (Velo and Abdullahi, 1976). In 
macromolecular terms the complexities have been unravelled to a 
greater extent and can be pieced together in schemes such as 
that shown in Figure 1.4 (after Goldstein, 1974) or more simply 
in Figure 1.5. The inflammatory cycle could be partially tempered 
by the secretion of the anti-proteases antitrypsin, macro­
globulin and plasmin inhibitors from the mononuclear phagocytes 
viiich follow the neutrophils, and the enzyine-inhibitor complex 
can be internalised and digested by macrophages (Nathan, Murray 
and Cohn, 1980). They also secrete the complement inhibitors 
C3b-inactivator and Cl-inhibitor (Nathan, Murray and Cohn, 1980).
It is the events of the first few hours that are of paramount 
importance in the successful killing of a bacterial focus, and they 
directly affect the size of the lesion formed. Normally, the 
short-lived tissue defences act quickly, but if interrupted by, 
for instance, decreased local blood flow, bacteria can multiply 
and increase tissue damage (Leak and Burke, 1974). The time- 
span of induration varies with the host and the invader, but 
it is maximal at about twenty-four hours. There is a central 
area of necrosis, which results from the infiltrating neutrophils 




system "Kinins «■ Chemotaxis
acid proteases neutralproteases
Gollagenolysis
t- . —Tissue injury
Plasmin 4. .proteasesp.a.
neutral pro teases Platelets
■» CoagulationFibrinolysis <r






venule basement membrane 
arterial elastin 
renal basement membrane 
cartilage
lur,g connective tissue
F i q u re 1.4 Inducers of inflammation.





Arrows indicate the direction of action, which may be
stimulatory or inhibitory, oi' both.
STIMULUS











F iq u re  1.5
The generation of an inflammatory cycle.
■ " \ A A A ^  represents crossing of the vascular endothelium
24
Monocytes in the tissues
The arriving monocytes by contrast are not so short-lived.
They mature into macrophages with well-endowed lysosomes and a high 
secretory repertoire to modulate healing. They have the capacity 
to phagocytose both bacteria and dead granulocytes, but their 
ability to kill microbes is dependent upon their state of activation 
(Nathan, Murray and Cohn, 1980). They are able to degrade inter­
stitial debris through the action of collagenase and elastase and 
fibrin by neutral proteases,to name but a few. As mentioned above 
they also release various enzyme inhibitors. The fate of the 
macrophages is poorly understood, but examination of the lymph 
nodes draining areas of inflammation, both acute and chronic, has 
suggested that many macrophages migrate to these nodes and transport 
dead and foreign material in their phagosomes. Moribund macrophages 
that die en route to the nodes may be phagocytosed by other 
migrating cells.
The presence of a large number of mononuclear phagocytes in 
the region of a stimulus probably enhances the lymphocytic response 
and resultant antibody production. Once coated with specific 
immunoglobulin the bacterium, for instance, would be more liable 
to be phagocytosed (Ehlenberger and Nussenweig, 1977; Henson,
1977). A continuing stimulus could be permitted through inefficient 
processing by either phagocytic cell type. Alternatively,the 
action of lysosomal enzymes in the extracellular milieu may 
uncover self antigens hitherto unrecognised by the host's immune 
system and so promote 'autoantibody'production (Fudenberg, 1978) 
and concomitant immune complex formation. The latter could activate
25
complement, induce more cellular infiltration and increase the risk 
of further destruction (Norman, 1974; see also Figure I.4) . The 
presence of local and circulating antibodies to host substances 
induced in thU way is common, but these are not necessarily patho­
genic. It has been suggested that the complexing of, for instance, 
anti-collagen to exposed collagen would enhance the removal of 
the damaged protein by macrophages (Johnson and Page Faulk, 1976;
Arend and Mannik, 1979).
These examples illustrate how improper control can allow for 
the development of a chronic inflammatory state. The relative rarity 
of its occurrence after an invasive episode indicates how well 
managed the sequence of events is in healthy individuals. When an 
acute response does not give way to healing, a continuing abnormality 
is manifest in one or more of the contributory factors, and a 
chronic inflammatory state results. Chronic inflammation always 
passes through an acute phase.
Cells in chronic inflammation.
Of great importance to the chronic inflammatory state is the 
continuing presence of a cellular infiltrate, in both the initial 
sites and in those that have newly developed because of the deposi­
tion of immune complexes. Mononuclear cells are predominant in 
these long-term lesions although small numbers of pblymorphs 
may continue to migrate for many months (Spector, Lykke and Willoughby, 
1967; Vernon-Roberts, 1972). The mitotic and phagocytic behaviour
of the macrophages can vary according to the nature of the lesion; 
the number that live for more than a few months ('long-lived') seems 
to be inversely proportional to the degree of cell turnover within
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a granuloma (Spector, 1974). The daily entry of monocytes from
peripheral blood into a Freunds Adjuvant-irritated site has been
measured in the rat foot and was calculated to be 2 x 10  ̂ per
24 hours, a constant figure over the twelve weeks of study
(Spector, Lykke and Willoughby, 1967). The total leucocyte influx
per day.into an inflamed human knee joint (in a patient suffering
9from rheumatoid arthritis) was calculated by Zvaifler to be 10 
cells (Zvaifler, 1971).
A number of these mononuclear phagocytes, the proportion 
depending upon the type of inflammatory stimulus, transform into 
persistent epithelioid^nd multinucleate giant cells (see below),
The characteristics of these cells have been studied in 'specific 
infective granulomata'; that is, those manifest in tuberculosis, 
syphilis and leprosy, which have a central zone of necrosis 
surrounded by these large cells (Vernon-Roberts, 1972). The 
epithelioid cell is an enlarged, mature form of the macrophage and 
can only develop if the latter has degraded all its ingested 
material. Low turnover granulomata, induced by for instance, 
carrageenan, contain macrophages that are full of undigested 
material; thus epithelioid cells rarely form. In contrast they 
are prominent in some high turnover reactions, such as that owing 
to B. Pertussis vaccine. The epithelioid cell is non-phagocytic, 
it divides into small, round cells which develop into typical 
macrophages which can in their turn become epithelioid cells 
(Spector, 1974). The multinucleate giant cell originates from 
the fusion of pre-existing macrophages and may contain as few as 
two, or in excess of fifty, nucleii, to be found at the cell periphery
27
(Vernon-Roberts, 1972). These giant cells take up experimentally 
administered carbon and thus have been shown to be present through­
out the reticuloendoethelial system (now called the mononuclear 
phagocyte system) and at sites of tissue reaction.
The fixed tissue mononuclear phagocytes, especially the Kupffer 
cells of the liver, are responsible for clearing circulating complexes, 
although in chronic states a blockade may develop as the cells 
become saturated.
Immune complexes and chronic inflammation
The presence of a raised level of circulating complexes is 
common in animals, including humans, chronically infected with 
viruses of different types (Oldstone and Dixon, 1971) Such complexes 
are associated with glomerulonephritis and/or arteritis (Leber and 
McCluskey, 1974). Soluble immune complexes of less than 19s pass 
through, rather than deposit at, the glomerular basement membrane: 
large lattices are phagocytosed by the Kupffer cells: so it is the
intermediate sizes that deposit (Cochrane, 1971). Most of these 
bind complement and this can be demonstrated with the use of 
fluorescein-labelled anti-C3 vhich follows closely the pattern 
found with fluoresceinated anti-immunoglobulin in the same , ' 
glomerulus (Cochrane, 1971; Oldstone and Dixon, 1971).
This tissue deposition and complement activation reinforces the 
inflammatory impetus by causing local tissue damage with the 
consequent chance of autoantibody formation. A likely consequence 
of the interaction of immune complexes and complement is hypocomple- 
mentaemia; in terms of the ongoing reaction this state might be
considered advantageous in regulating the response, but the 
ability of the host to opsonize infective bacteria would also 
be impaired.
Autoantibodies do develop in infections, especially in 
prolonged ones with specific infective granulomata, in which 
the host is ineffective in combating the disease. This auto-antibody 
formation is the case, for example, in patients suffering from sub­
acute bacterial endocarditis, where the specificity of the anti­
bodies range from anti-IgG ('rheumatoid factor ') and antinuclear
to
factor to anti-thyroid cell antibody.  ̂Ubiquitous exogenous 
antigens such as Candida have also been found to be common despite 
an apparent absence of, for instance, this organism. The incidence 
of the auto-antibodies paralleled more severe and persistent 
disease and decreased markedly with recovery of the patient.
(Bacon, Davidson and Smith, 1974). Circulating complexes were 
found in all patients with definite infective endocarditis by 
Burton-Kee and workers (Burton-Kee, Morgan-Capner and Mowbray,
1980), although the presence of antigen in these complexes could
not be demonstrated. They too noticed the presence of 'rheumatoid factor'
in the serum which correlated with complement binding IgG and IgA
complexes. During the time that circulating immune complexes are
produced during an acute infection, such.as in typhoid fever,
they too are accompanied by this anti-immunoglobulin G activity
Rajagopalan, Kumar and Malaviya, 1981) .
Rheumatoid factor and its specificity
Rheumatoid factor (RF) derives its name from the disease in
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which it is most commonly found, that is, in rheumatoid arthritis. 
It is present in the serum of between 60 and 80% of patients with 
this disease, where it persists, often at high titre, in contrast 
to the transient nature of its appearance during acute infection. 
Johnson and Page Faulk (1976) have compiled a comprehensive review 
of its properties, knowledge of which has accumulated since the 
1940's when rheumatoid sera were seen to be able to agglutinate 
sheep erythrocytes sensitized with rabbit antibody. This 
publication has therefore been extensively drawn upon in the foll­
owing section.
The RFs that have the ability to agglutinate IgG-coated 
latex particles and red cells, and to precipitate soluble aggre­
gates of IgG, are IgM antibodies directed against antigenic 
moieties on the Fc portion of human IgG, although there is a 
cross-reaction with rabbit IgG. This IgM RF is almost always 
19s (pentameric), the ten possible valencies being reduced to 
five in practical terms because of steric hindrance. The 
monomeric subunit, low molecular weight IgM, can be demonstrated 
by. radio-immunoassay (RIA) techniques, and is implicated in the 
disease process (Roberts-Thompson, Wernick and Ziff, 1981). IgG 
RF activity is poorly detected using agglutination techniques 
but more sensitive RIA have shown it to be present in the sera 
and synovial fluid from rheumatoid patients both seropositive 
(i.e. positive for IgM RF) and seronegative (Shakib and Stanworth, 
1978; Allen et al,, 1981).
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Both 19s (IgM) and 7s (IgG) antiglobulins in sera from 
rheumatoid arthritis patients have been found to be enriched for 
K-light chain containing antibodies in comparison to the ratio of 
kappa to lamlDda in each individual's globulins (19s + 7s)
(Carson and Lawrance, 1978). Patients with sub-acute bacterial 
endocarditis show a similar change in the 19s antiglobulins, but 
not in the 7s. This predominance has been demonstrated, experimen­
tally, to occur as a result of repeated stimulation with antigen, 
and the above authors suggest that the presence of kappa-chains 
may represent an idiotypic marker related to rheumatoid factor 
production.
The study of the specificity of RF has largely been confi ned 
to that of the IgM-antiglobulin, and has followed three general 
directions: determinants on native IgG; on complexed but not
native IgG; and on hidden sites only exposed following enzymic 
treatment.
In the first case, the genetically-determined immunoglobulin 
allotypes looked interesting. In accordance with the WKÜ 
recommendation (World Health Organization, 1976), the terminology 
for these is Gm (y-chain markers), Km (K-chain markers) and Am 
(a-chain markers) with a number denoting the subclass on which the 
are found e.g. Glm, A2m. The Gm markers have been the most comp­
rehensively studied and at least 22 are known and identifiable.
In normal sera the anti-Gm activity is usually of the IgM class 
(Divall and Khalap, 1976) and reacts only with the IgG that 
carries the antigenic marker for which it has specificity. The 
subject himself is not positive for that determinant. In contrast.
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IgM RF is not specific in this way though it may act as an anti-Gm 
agglutinin. It can be inhibited not only by the appropriate Gm 
positive serum but also by the negative, and it can also react 
with autologous IgG. The allotypes are mutations at single, 
or a narrow range of, aminor-acids in the polypeptide chain and 
their antithetic markers are therefore widely distributed amongst 
the immunoglobulins. It is these that could well be implicated 
in the reactivity of RF (Gaarder and Natvig, 1970; idem, 1972), 
but if so they seem to occur concurrently with activity towards 
a non-allotypic determinant called Ga (Gaarder and Natvig, 1970; 
Gaarder and Michaelsen, 1974).which was originally detected by 
Allen and Kunkel (1966) in a rheumatoid donor. This patient's 
antibody circulated complexed to her own IgG and was dissociated 
on an acidic gel-filtration column. The Ga antigen is present 
on IgGl, 2 and 4, but not IgG3;& interestingly the reaction of 
IgM RF and rabbit IgG too has been found to be inhibited by 
all subclasses but IgG3 (Gaarder and Michaelsen, 1974). The Fc 
region of IgG inhibits the reaction between anti-Ga and its 
substrate (Allen and Kunkel, 1966). It has been suggested that 
RFs interact with antigens located on both homology regions of 
the Fc fragment, one on the Cy3 and three on Cy2 (Natvig, Turner 
and Gaarder, 1972).
There is some,controversy as to whether RF can bind to 
native as well as to complexed or aggregated IgG. Certainly it 
binds far better to the latter, which suggests that new antigens 
may appear as a result of the conformational chnages that have 
occurred. The finding that circulating RF is found complexed
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with monomeric 7s IgG as in the case of the patient Ga, above, 
suggests that the IgG may not be native but instead may already 
be bound to an as yet undefined antigen. Alternatively, the 
interaction may be more efficient solely because of the increased 
local concentration of the IgG molecules.
The sera and joint fluids of patients with rheumatoid arthritis 
often contain antibodies with activity towards areas uncovered by 
pepsin digestion of normal IgG. These so-called 'pepsin agglutin- 
ators' are also found in some chronic infections and in normal 
sera. They show a specific reactivity towards the F(ab')2 fragment, 
vhich is similar to that produced by lysosomal protease action.
This hints at a usefulness in clearing IgG that has been degraded 
during the inflammatory response in much the same way that anti­
collagen antibodies are produced to remove damaged fibres. The 
cross-reactivity of rheumatoid factor activity and the presence 
of other autoantibodies in rheumatoid arthritis are discussed in 
a following section.
Rheumatoid factor and complement fixation.
Monoclonal IgM RFs manifest a variation in complement-fixing 
ability but those in heterogenous polyclonal serum can do so when 
bound to complexed IgG. The interaction between RF and IgG- 
coated latex particles has been shown to be modified by the presence 
of complement in fresh serum, or isolated Cl component (Hallgren, 
1980). This factor is thought to bind avidly to the 'complexed'
IgG and decrease the ability of the RF to also bind. If, however, 
the complement is artificially activated, the interactions are not 
inhibited.
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IgG from plasma only poorly energizes complement, if at all 
(Pope, Teller and Mannik, 1975), but if bound to IgM RF the 
stabilized form may allow the latter to act upon complement (Allen 
et al,, 1981). Winchester, Agnello and Kunkel (1971) characterized 
the IgG-IgG complexes that are found in the serum and the joints 
of rheumatoid arthritis patients and interestingly discovered 
that those in serum did not bind complement while those in the 
synovial fluid did so readily (Winchester, Kunkel and Agnello,
1971; Winchester, 1975).
The pepsin agglutinators discussed above exhibit negligible 
complement fixation.
Rheumatoid factor and its relevance to rheumatoid inflammation.
The presence of IgM RF in serum seems to have some prognostic 
implications for the patient, with high levels being associated 
with more severe disease and systemic manifestations such as 
cutaneous vasculitis and nodules. Recently a strong correlation 
between IgG RF and vasculitis has been noted (Allen et al., 1981; 
Scott D. at al,, 1981). The patients in this study (Scott D.G.I. 
et al., 1981) were found to have circulating complexes with 
anti-complementary activity, and serum C4 levels below the .normal 
range, which indicated that the IgG RF-containing complexes bound 
complement. IgM RF was also present in the sera.
Self association between IgG RFs was noted by Pope, Teller 
and Mannik (1975) and IgM/igG by Jones and colleagues (1980); 
this may generate intermediate-sized complexes which could account
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for the plasma hyperviscosity that tends to be found in patients 
with rheumatoid arthritis.
Whether an IgG molecule is bound to a small antigen or to 
another IgG molecule, the addition of an anti-immunoglobulin will 
increase the size of the complexes and possibly their tissue 
deposition (Cochrane, 1971) and promote their removal by scaven­
ging granulocytes or monocytes, or by the Kupffer cells. This 
deposition could promote the risk of incomplete phagosome formation 
with the possible consequences that have been discussed in a 
previous section. On the other hand, IgM RF might decrease their 
uptake by neutrophils since these cells do not
have IgM receptors (Ehlenberger and Nussenweig, 1977).
The effect of both IgG and IgM RFs on the formation and 
processing of DNA/anti-DNA complexes has been studied by Lamers 
(1980 and 1981). He discovered that the effect of the IgM RF 
was very dependent upon the size of the complexes and the presence 
of complement, whereas IgG RF increased the size and processing 
of small complexes but had virtually no effect on large ones.
Alkner and Hansson (1979) have noted that IgM RF affects the 
equilibrium of antigen-antibody reactions.
Since the major feature of rheumatoid disease is arthritis, 
the presence in the synovium and synovial fluid of rheumatoid 
factor has been investigated. The technique of immunofluorescence 
has been used to demonstrate the presence of IgG, IgM and 
complement in a wide range of synovial tissues from rheumatoid
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patients, but this provides circumstantial evidence only for the 
presence of complexes. Plasma cells are concentrated in inflamed 
synovium and appear to contain RF activity. This can, however, 
only be successfully demonstrated after a pepsin digest of the 
tissue has been made, which has been interpreted to mean that 
self-association of IgG RF has already occurred (Natvig and 
Munthe, 1975).
The possibility that RFs are only secondary to the disease 
process has been reinforced by sane evidence. Anti-immunoglobulins
are present in diseases other than rheumatoid arthritis, as discussed 
previously, and only decrease as the patient recovers. Patients 
with hypogammaglobulinaemia can suffer from a rheumatoid-like 
arthritis without producing any RFs; and only a few youngsters 
with juvenile rheumatoid arthritis (JRA) develop rheumatoid 
factor.
It might be helpful to type the specificity of the anti-anti­
body activity from infectious diseases and make a comparison with 
the anti-Ga activity of rheumatoid sera.
Linked to the pathogenesis of these factors is the stimulus 
for their production, and this is as yet unknown. There are a 
number of theories, some of which are outlined below.
A popular theory at present is one in which the immunoregulatory 
system is aberrant, a state possibly induced by a chronic viral 
infection (Depper and Zvaifler, 1981; Fudenberg, 1980; Panayi,
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Corrigall and Youlten, 1981). The Epstein-Barr virus (EBV) can 
cause a number of diseases in which alterations of the immune system 
occur, for instance infectious mononucleosis (which is accompanied 
by autoantibody production) and Burkitt's lymphoma (Depper and 
Zvaifler, 1981). When cultured mononuclear cells are infected with 
EBV, they can transform into permanent cell lines, a process 
followed by rising levels of IgM in the culture supernatant. When 
the cells are derived from rheumatoids, in comparison to normals, 
the amount and affinity of the IgM anti-IgG produced is higher in 
the former group, though the total IgM remains similar (Slaughter 
et al., 1978). Normal human lymphocytes can likewise be stimulated 
by pokeweed mitogen to secrete IgM RF in vitro (Koopman and 
Schrohenloher, 1980). Lymphocytes apparently uninfected with 
EBV had higher transformation scores in RA patients (6 of 11) 
compared to normal controls (2 of 10), suggesting persistence of 
the virus within the mononuclear cells. The work of Alspaugh and Tan 
(1976) and Alspaugh et al. (1978) has also indicated that this is 
the case, because about two-thirds of rheumatoid sera (sero-positive) 
contain an antibody to a nuclear antigen present in human lymphocyte 
cell lines, and which is expressed when such cells have been trans­
formed specifically by EBV. This was termed RANA (rheumatoid arthritis- 
associated nuclear antigen) to distinguish it fron the Epstein-Barr 
nuclear antigen, EBNA. EBNA is expressed only transiently after the 
cell is infected; by contrast RANA is permanent. Only eight 
percent of normal sera have such antibodies. About eighty percent 
of the world's population have been infected with EBV, usually 
asymptomatically, so that if it is to be implicated as a causative 
agent in rheumatoid arthritis, environmental and personal factors
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need to be considered (Panayi, Corrigall and Youlten, 1981).
A caveat to the study of antibody activity such as that 
described above is that rheumatoid factor shows a marked degree 
of heterogeneity in the antigens with which it can bind. For instance, 
Johnson has extensively studied its expression of an anti-nuclear 
activity unrelated to RANA (Johnson, 1979, 1980) and Bokisch.,and 
colleagues (1973) have reported a strong cross-reactivity towards 
peptidoglycan in a rabbit 7s anti-IgG that was produced during 
immunization to streptococci.
A very different idea to that of abnormal immunoregulation 
is that RF production is stimulated solely because the patientis 
IgG has become immunogenic, either by complexing (with antigen 
or another immunoglobulin), aggregation or enzymatic digestion.
This maybe the stimulus for its production in acute illness as 
mentioned previously. The antigenicity generated might well 
depend upon the nature of the antigen that was bound. Related to 
this is the concept that the patient's IgG is inherently structurally 
altered. Circular dichroism (CD) has been used to study the con­
formation of immunoglobulins. In comparison to a normal reference, 
immunoglobulin G from RA patients has been shown to have altered 
CD spectra around two wavelengths, namely 280 nm and 294 nm, vhich 
reflect hinge regioh (certain disulphide bonds) and tryptophan 
resonance respectively (Johnson et al., 1974). The differences are 
probably attributable to IgG anti-globulins or the IgG to which 
they are attached. This idea has recently been strengthened by 
Alkner and co-workers (1982) who have shown that IgG complexes with
38
RF activity, isolated by affinity chromatography, show similar changes 
while the patient's monomeric IgG has behaved normally. This is 
the case under dissociating as well as neutral conditions which 
indicates an intrinsic, rather than antigen-binding, aetiology.
The deviant conformation at the hinge region is interesting because 
this area can influence binding to membrane Fc receptors, and thus 
indirectly to B-lymphocyte responsiveness (Johnson et al., 1975; 
Johnson, Watkins and Holborow, 1975).
There is evidence from the Gm and Km systems that rnaterno- 
foetal incompatibility can result in eitlier mother or baby, or 
both, being actively immunized by the other for the non-shared 
allotypes. Investigation did not implicate these in JRA at 
least,, It has been of interest because only IgG crosses the 
placenta, and RF reacts solely with IgG amongst the immunoglobulins.
It has been stressed that the presence of rheumatoid factor is a 
characteristic of some infective processes, but that it tends to 
be transient. The disease in which it was first found, and in 
which it is most commonly, and continually, present is rheumatoid 
arthritis. No infective organism, in whole or part, has, as yet, 
been shown to be the causative agent in this chronic inflammatory 
disease (e.g. Wilkes at al., 1973). The fact that the persistance 
of a virus within a joint can cause a long-term arthritis has recently 
been illustrated in'a study of five patients who failed to show 
clinical symptoms of Rubella infection (Grahame et ai., 1981).
Despite this, a cytopathic agent indistinguishable from rubella 
virus was demonstrated in their synovial fluids and all patients had 
high haemagglutination titres to rubella. A transient arthritis
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concurrent with a clinically evident rubella infection is not un­
common. Interestingly, like RA (Masi and Medsger, 1979), it 
occurs predominantly in females (Grahame et ai., 1981). The 
difference between this major group (transient symptoms) and the 
minority of patients with chronic synovitis (discussed above) 
stresses the importance of the host's immune system in handling 
foreign agents, a factor discussed in the previous section.
Gastrointestinal infections with organisms such as Yersinia, 
Shigella or Salmonella can also be followed by a reactive arthritis. 
Individuals who are susceptible to this tend to be HLA-B27 positive 
(Laitinen and Leirisalo, 1981). This reinforces the suggestion 
that there is genetic control over the inflammatory and immune 
states.
Rheumatoid arthritis; pathogenesis.
Rheumatoid arthritis is a disease in which the control of 
these processes seems to be aberrant, and which is probably multi- 
factorial in origin (Panayi, Corrigall and Youlten, 1981). It is 
primarily a disease of joints, and is first manifest as inflammation 
of the synovium, which then progresses to a proliferative synovitis 
which results in damage to bone, cartilage and tendons. The early 
synovitis is characterized by an increase in blood flow to the 
synovium; a migration of granulocytes from the circulation into 
the joint space, and of mononuclear cells into the perivascular 
regions of the tissues. The predominance of polymorphonuclear 
leucocytes witliin the fluid persists even in the chronic state, 
when they form about 70% of the 19 million leucocytes per ml., on
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average, found in the rheumatoid joint (Cohen and Skinner, 1979).
The pro-inflammatory nature of leucocyte secretions has been dis­
cussed in a previous section, and.may explain the establishment 
of the chronic inflammatory state. The abnormal highly vascular and 
cellular synovium interacts with connective tissue cells to form 
a pannus that progresses from the joint periphery towards its 
centre, eroding cartilage and bone along its path (Harris, 1979). 
Histological and electron microscopic studies of the pannus-cartilage 
junction have identified granulocytes (Mohr, Westerhellweg and 
Wessinghage, 1981) as well as mononuclear and synovial cells, and 
the tissue destruction is likely to be mediated by enzymes from
several cell types (Harris, 1976). The inhibitory proteins ar2.
macroglobulin and anti-trypsin may become saturated, both locally 
and in the synovial fluid, and thus unable to regulate enzyme 
activity.
The processes of erosion and proliferation alter the archi­
tecture of the joint such that it is less moveable and may undergo 
partial subluxation (Gardner, 1972): but it also uncovers
potentially antigenic moieties through the action of the secreted 
enzymes. Proteolgycan and collagen are both damaged by the
progressive degradation (Lancet, 1977). Giant and co-workers 
125have used an I-radioimmunoassay (solid phase) to detect anti-
proteoglypan antibodies in the sera of eleven out of twenty-nine 
patients with RA, and in 4 of 6 rheumatoid synovial fluids (Giant, 
Csongor and Szues, 1980). Neither normals nor ankylosing spondilitis 
patients' sera reacted to the antigen, proteoglycan of human 
articular cartilage. Leucocyte migration inhibition and lymphocyte
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stimulation, that is cell-mediated immunity, were also demonstrated 
during the same study.
Menzel (Menzel et ai., 1978) utilized a ^^C-radioimmunoassay 
to demonstrate the presence of antibodies to denatured type I 
human collagen in RA synovial fluids; 20/27 (74%) were positive, 
sixteen of which also gave a titre of greater than 1 in 16 by passive 
haemagglutination. Antibodies to native collagen were found in only 
eight of the twenty-seven, and inhibition experiments suggested 
that this activity was because of cross-reacting anti-denatured-collagen 
antibodies. Similar inhibitory tests indicated that there was 
also cross-reactivity towards type III denatured collagen. The use 
of immunofluorescence has detected anti-collagen antibodies in just 
3% of patients, most of which were highly specific towards type II 
collagen (Beard et ai., 1980). Hie disparate frequency of these 
results may be partly explained by the different techniques used, 
immunofluorescence being less sensitive than radioimmunoassay.
In agreement with Giant's work with proteoglycans, Stuart 
et ai. (1980) have found that peripheral blood MNC from patients 
with joint diseases have been shown to possess cell-mediated 
immunity towards native collagens and their a-chains. The. 
immune activity was more frequent and intense with RA patients 
than, for instance,ankylosing spondilitis victims or normals.
For native collagens this was 50, 20 and zero percent respectively, 
and towards denatured a-chains 90, 50 and 10 percent.
Some cross-reactivity between human Clq and human collagen
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has been demonstrated in a delayed-type hypersensitivity reaction 
in guinea pigs (Menzel, Smolen and Reid, 1981). It is conceivable 
that the presence of complement-binding immune complexes might 
therefore enhance this cellular activity.
The presence of collagen/anti-collagen immune complexes has 
been indicated in synovial fluid cells from RA patients (Steffen, 
Ludwig and Knapp, 1974).
Immunoglobulin is secreted by rheumatoid synovial membrane 
(Smiley, Sachs and Ziff, 1968) and may itself by damaged by 
proteolytic action and so become immunogenic. But as an antibody 
it could bind to its antigen (either the causative agent or host 
neo-antigens) and be altered by virtue of its being complexed.
This change has been discussed in the previous section.
The arthritic joint exhibits many of the features found in 
chronic inflammatory states and which were outlined in Figure 1.4.
For instance, leucocytes are induced to migrate from the capillaries 
(chemotaxis). The same vessels become more permeable and allow 
seeping of macromolecules such as clotting factors and fibrinogen 
into the environment ; fibrin is deposited on, and in, the synovium 
(Harris, 1979). These examples, whatever their cause, probably 
provide enough impulsion to start the wheel of inflammation revolving.
Synovial tissue and fluid.
The native synovial cells may themselves be important in 
this cycle. There are basically two major types of synovial cell;
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Type A (macrophage-like) and Type B (fibroblast-like). The former 
have surface villi and sparse endoplasmic reticulum (ER), and 
their lysosomes become more abundant in RA, where residual bodies 
are also found in the cytoplasm (Gardner, 1972): both indicate
active phagocytosis. The Type B cells possess abundant ER which 
is probably involved in making glycoprotein for export. Barratt 
and colleagues (1977) have made a study of pig synovium and have 
concluded that the synoviocytes of the superficial layer belong 
to one cell type. They assume either the A- or the B- type 
according to local environment conditions.
Synovial fibroblasts secrete hyaluronic acid, and rheumatoid- 
derived cells, in vitro, have been shown to secrete a hyaluronate 
that is less viscous than normal. Since the normal, high molecular 
weight compound has anti-inflammatory effects (Harris,1979), the 
altered species may have a profound effect on the ongoing cellular 
response.
Giant multinucleate cells are also found in the synovium and 
tend to be associated with the presence of IgM RF in the plasma 
(Gardner, 1972) . They are probably of macrophage origin (Harris, 
1979) as has been found at tissue reaction sites in other diseases 
(Vernon-Roberts, 1972).
Structural features of the joint have a bearing on the 
disease process for the loose organization of cells in the synovium 
allows its proliferation in arthritis. The encapsulated nature 
of the joint means that there can be an influx of viable granulocytes
44
towards a stimulus, but limited exit for the moribund cells, which 
must therefore be degraded in situ. The vast increase in cell 
numbers,although concurrent with an increased blood flow, leads to 
a decrease in the partial pressure ofoxygen and of pH as the pCO^ 
and lactate levels rise (Harris, 1979). Many of the lysosomal 
enzymes that enter the fluid by exocytosis are acid hydrolases 
vhich degrade their substrates more efficiently at acidic pH.
This may facilitate the damage to cartilage that occurs independ­
ently of the pannus.
Immune complexes have been shown to be present in synovial 
fluid, and sera, frcm RA patients (Winchester, Kunkel and Agnello, 
1971) and are thought to be responsible for perpetuating the 
inflammatory response (Male, Roitt and Hay, 1980). They certainly 
have the ability to initiate and maintain extra-articular reactions; 
vasculitis is associated with high levels of IgG RF and raised 
immune complexes (Allen et ai., 1981; Scott D.G.I. et ai., 1981) 
as has been found in animal models (Leber and McCluskey, 1974). The 
subcutaneous and pulmonary nodules that are found in some RA 
patients are also vasculitic in origin (Harris, 1979; McGuire 
and Harris, 1979). The measurement and analysis of complexes 
with respect to RA has, therefore, been popular (e.g. Onyewotu 
et ai., 1975; Erhardt, Mumford and Maini, 1979; Male, Roitt 
and Hay, 1980). However, there is a lack of correlation between 
the many different assays available because they are specific 
for different properties, and this has made the interpretation 
of data difficult (Soothill, 1977)..
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The presence of activated C4 in synovial fluid containing 
complexes indicates strongly that the latter are major activators 
of complement (Male, Roitt and Hay, 1980) in this specific case 
as well as in general (Figure 1.4).
Regulation
The multiplicity of possible regulatory sites in the inflam­
matory process makes the study of chronic inflammatory diseases 
very complicated. Given that rheumatoid arthritis is of unknown 
etiology, it is valid to ask if there is sane cellular or humoral 
defect in immunoregulation, either in isolation from, or related 
to, an infectious agent (Fudenberg, 1980; Panayi, Corrigall and 
Youlten, 1981). Specific investigations of leucocytes, and in 
particular phagocytes, will be discussed in subsequent chapters.
The properties of the granulocytes would seem to be particularly 
important since they are the first cells to reach a pro-inflammatory 
site, and to ingest and degrade an offending organism. The 
closely following mononuclear phagocytes are much longer living 
and are thus very important in chronic lesions. It was therefore 
decided to study some of the properties that these cell types 
manifest, in particular those related to their interaction with 
complexed immunoglobulin including rheumatoid factor. The 
phagocytes from rheumatoid arthritis patients and healthy controls 
were to be compared in these respects in order to ascertain if 
any differences existed.
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CHAPTER 2. GENERAL METHODS
1. Preparation of cells;
The anti-coagulant used in most instances was citrate,
1.1 millilitres (mis) of 0.106 M trisodium citrate being used 
for 10 mis of peripheral blood. For seme experiments, preser­
vative-free heparin was used at 125 U per 10 mis of blood.
The leucocyte populations were separated from one another 
using either Percoll or Ficoll-Paque (Pharmacia Fine Chemicals), 
according to the methods outlined in the following chapter.
Where red cells contaminated the leucocyte preparations, they 
were removed by differential lysis using an ammonium chloride 
solution of the following composition:
155 mM NH^Cl 
10 mM KHCO^
0.1 mM EDTA
This has a final pH of 7.3 - 7.4 (Weening, Roos and Loos, 1974). 
One ten minute treatment with the above was usually sufficient 
to remove the unwanted cells. The leucocytes were washed a 
further twice (whether or not they had undergone this treatment), 
in an iso-osmotic PBS containing 0.2% w/v egg albumin (Sigma), 
termed PESA. They were then resuspended in PBS or in tissue 
culture Medium 199 containing 20 mM HEPES and 10% heat-inactivated 
foetal calf serum (FCS) (Wellcome and Gibco-Biocult).
2. Evaluation of cell preparations:
All cell counts were carried out in white cell counting 
fluid containing 3% acetic acid and 0.1% methylene blue (British
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-1Drug Houses) and all cell viabilities in trypan blue (0.2 g dl ) 
in PBS, using a Neubauer counting chamber.
A cytocentrifuge (Shandon Southern, Runcorn) was used to make 
the cytological preparations. Approximately 2 x 10^ cells were 
resuspended in 3 mis of cold PBSA and spun onto four slides 
at 500 r.p.m. for ten minutes. The slides were air-dried, 
fixed in methanol and stained for ten and twenty seconds in 
the eosin and haematoxylin-based stains respectively, of 
Diff-Quick (American Hospital Supplies Ltd.). Each stained 
preparaticai, including blood smears fixed and stained as above 
was mounted under a cover-slip with DPX (Raymond Lamb Ltd.).
3. Phagocytosis assays;
The stimulus that was used most commonly was human IgG
that had been prepared from an IgGl myeloma serum (see section
2.5(iii)). It was aggregated at 60°C for 30 minutes at a protein
"“1concentration of 4.25 mg ml (section 2.5(vii)). This aggregate 
was particulate and had an anti-complementary activity (ACA, 
performed by Immunology Department, Royal United Hospital, Bath) 
of greater than 1 in 4096. When the aggregate was centrifuged 
at 5000 g for 30 minutes and the supernatant subject to gel 
filtration on Sepharose 6B-C1 (Pharmacia), there was no evidence 
of IgG being present.
Another IgGl myeloma, when purified, reacted to heat 
differently and produced a soluble, not a particulate aggregate 
with an ACA of 1 in 32. This was referred to as soluble 
aggregate (see Section 2.5 (vii)).
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The assays were set up in polystyrene tubes (Luckams Ltd.,
Sussex), with neutrophils at a final concentration of
6 —1 6 —15 X lO ml and monocytes at 1.25 x 10 ml in M 199 plus
10% FCS, with or without the stimulus at the desired concentration
The stoppered tubes were incubated at 37°C for one hour on a
rocking table (4RT/6-10,Luckams). Subsequent to this, they were
ospun at lOOO g for 15 minutes at a temperature of 4 C, and the 
supernatants harvested. For lysates, each cell pellet was 
made up to the original incubation volume with a solution of 
0.1% bovine serum albumin (BSA) with 0.1% Triton-X-lOO in 
saline. This was well mixed and then centrifuged at 5000 g 
for 25 minutes. The supernatants were harvested. The test 
supernatants and lysates were used fresh, or stored for up to 
two weeks at -20°C, for the estimation of the lysosomal enzymes . 
The estimation of lactic dehydrogenase (LDH) was always carried 
out on fresh samples.
4. Enzyme assays:
Four different lysosomal enzymes were assayed, and the 
details are laid out in Table 2.1. All the substrates and 
standards were purchased from Sigma (Poole, Dorset) and other 
chemicals from BDH (through Ferris, Bristol). When the levels 
of the 6-glucuronidase and 3~galactosidase were measured in 
cell lysates, the sample volume that was added was halved, and 
the corresponding values doubled. All four enzymes were 
measured by endpoint reactions, while the lactic dehydrogenase 
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5. Preparation of protein solutions:
(i) Chromatography and Estimation
All the chromatographic reagents were purchased from 
Pharmacia Fine Chemicals, whose columns were used in most 
procedures. Comparable apparatus manufactured by Wright 
Scientific Ltd. was also used. Fractions were collected and 
recorded on an LKB 7000 fraction collector and chart recorder. 
Protein estimations were carried out by the method of Lowry et al 
(1951). Where the size of the sample precluded this, the concen­
tration was calculated from its optical density at 280 nm, 
according to the following equation:
-1Abs28o X 0.72 = concentration (mg ml X
(for immunoglobulins)
(ii) Purity of the preparations.
The immunodiffusion was carried out in 1% agar made 
up in 0.05 M Tris HCl pH 8.5 containing 0.1% sodium azide.
The immunoelectrophoresis was carried out on glass photographic 
plates coated with 1.5% agar in barbitone buffer in a bath 
filled with sodium barbitone/acetate buffer pH 8.6. It was 
run at approximately 40 mA, 200 V for 2.5 hours with bromo- 
phenol blue as a migration indicator. Shandon Southern equip­
ment was used. Once this stage had been completed, antiserum 
was added to the troughs and an incubation carried out at room 
temperature overnight in a moist chamber. After drying, the 
plates were stained for 30 minutes with 0.1% Ponceau S in 3% 
trichloroacetic acid, and destained in 5% acetic acid followed 
by fixing to tlie plates in 2% glycerol for 2 hours. The
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immunodiffusion plates were also stained in this way following 
extensive washing in saline. This staining method, and that 
of the IgG preparation (see below) are routinely used at the 
Scottish Antibody Production Unit, at Law Hospital, Lanarkshire 
(SAPU).
Antisera were purchased from Boehring, except for the anti-human 
IgG Y~chain specific which was kindly donated by Dr. A. Munro 
of SAPU.
(iii) IgG was purified from human myeloma serum as follows:
A DEAE-Sephadex column (1.5 x 30 cm) was prepared
equilibrated in 0.02 M phosphate buffer, pH 6.2. Five mis of 
the patient's serum was dialysed against the same buffer for 
24 hours at 4°C and applied to the column. The IgG was eluted 
in the same buffer and was dialysed back to neutrality against 
PBS, in a positive pressure Amicon unit with a PM 50 membrane.
All other proteins were eluted from the column with 2 M NaCl in
0.02 M phosphate, and discarded. The IgG was pure by immuno­
diffusion (Ouchterlony) and by immuno-electrophoresis.
(iv) Fractionation of synovial fluid:
The following method was used to isolate putative 
immune complexes from rheumatoid synovial fluid.
The euglobulin fraction was precipitated with 45% ammonium sulphate 
and allowed to flocculate overnight at 4°C before being washed 
twice with 45 % ammonium sulphate. The precipitate was dissolved 
in 20 mis of 0.02 M phosphate buffer, pH 6.2 and dialysed for 
36 hours against the same buffer before being passed over
DEAE-sephadex as described above (Section 5 (iii)). Complexes 
could not be further separated from the bulk of the IgG using 
a Sepharose C1-6B column (Wright) in PBS, pH 7.4. The buffer 
contained 10 mM phosphate and 150 mM NaCl. The column used 
was 1.6 X 90 cm and was run at 8 mis per hour with a positive 
peristaltic pump (LKB).
The IgG peak was aliquoted and stored at -90^C, at 
“I2.9 mg ml . This preparation had an ACA of 1 in 512, which 
decreased slightly to 1 in 128 after eighteen months storage.
(v) Rheumatoid factors;
IgM rheumatoid factor, purified by the Degalan Column 
technique (Johnson, 1979) was kindly provided by Dr. G . Onyemelukwe 
(University of Liverpool). The mixed IgM plus IgG rheumatoid 
factor was donated by Dr. C. Elson (University of Bristol), 
who prepared it from the serum of a patient attending the 
Rheumatic Diseases Hospital in Bath.
(vi) Preparation of immunoglobulin allotype reagents ;
The IgM fraction of an anti-Glm (f) serum was prepared 
by dialysis of the serum against distilled water for 48 hours.
The resulting precipitate was centrifuged at 2,200 g for 20 
minutes and the supernatant discarded. The pellet was resuspended 
in 10 mM phosphate/150 mM NaCL pH 7.4 and allowed to dissolve 
overnight at 4°C.
Small aliquots of about three milligrams each were applied
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to a Sepharose CI-6B column, 1.6 x 90 cm in the same buffer, 
run at 8 mis per hour, as above. The first peak and its 
shoulder were pooled and concentrated in an Amicon unit to 
2.5 mg ml This contained three components by immunoelectro­
phoresis: IgM, macroglobulin and lipoprotein. One percent
bovine serum albumin was then added to stabilize the IgM solution.
The activity of both antiserum and IgM fractions towards 
Glm (f) positive IgG was evaluated by a standard haemagglutination 
assay. This involved sensitizing a pool of Group O positive 
red cells with an anti-D positive for Glm (f). This was carried 
out at 37°C for 1 hour after washing of the red cells in PBS, 
and was followed by further extensive washing to remove un- 
reacted anti-D.
The antiserum or IgM fraction was allowed to react with 
them at room temperature for one hour in small polystyrene 
tubes. After a short centrifugation, 35 g for 3 minutes, the 
cells were carefully streaked onto a grease-free glass plate 
and studied for the presence of agglutination.
IgG from a Glm (f) positive serum was prepared using the same 
method as that used for the myeloma IgG.
All the IgG.allotype reagents were kindly provided by 
Mr. P. Holt of the Blood Transfusion Service at Southmead 
Hospital, Bristol.
(vii) Aggregation of IgG:
The IgGl myeloma (Mrs H) with which most of the
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experimental work was carried out was found to aggregate and 
precipitate out very easily at 60°c or above. Samples of the 
purified IgG at 4.25 mg ml ^ in PBS were incubated at 60°C for 
increasing periods of time, plunged into crushed ice, then 
centrifuged at 2000 g for 20 minutes. The protein concentration 
of each supernatant was measured and the amount of non-precipitated 
protein calculated. It can be seen from Figure 2.1 that by 20 
minutes all but 17% had become particulate. Routinely, the 
IgG was incubated for 30 minutes at 50°C.
A second IgGl myeloma (Mrs W) was prepared and heat treated 
in the same way. The solution became neither opalescent nor 
particulate although some aggregates were formed because it 
exhibited an anti-complementary activity of 1 in 32 (compared 
to 1 in 4096 for "Mrs H"). The conditions for aggregation 
were altered, increasing the protein concentration, the temperature 
and the length of incubation but no further changes were induced.
The degree of aggregation of gamma globulins is known to 
be variable and was studied in depth by Morse (1965). She 
isolated the gamraa-globulin fractions from eighteen myeloma sera 
and two normal sera, as well as using a commercial source of 
pooled human Cohn fraction II. Each was heated for up to 15 
minutes at 63°C and their anti-complementary activity and 
rheumatoid factor binding activity (by precipitation) measured. 
Representative samples were subjected to ultracentrifugation 







The aggregation of myeloma IgG.
ordinate: mg ml*"^ of IgG remaining in solution.
abscissa: time of incubation,in minutes, at 60°C. Time
zero equalled the point at which an equivalent 
solution reached 56°C.
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I. Four of the eighteen myelomas became heavily opalescent
—at 1 mg ml ( and were complement-activating) and precipitated 
—1at 10 mg ml . Ninety percent was aggregated after only 3 
mins at 63°C.
II. Three of the eighteen became anti-complementary on heating
—1at 10 mg ml , at which concentration all were precipitated 
with rheumatoid factor. About 50% of one sample was seen to 
be aggregated upon ultracentrifugation analysis.
III. The larger proportion (11 of 18) became neither opalescent 
nor anticomplementary and contained no aggregates.
IV. The normal IgG's became opalescent and were 20% aggregated.
A full description has been given in order to indicate that "Mrs 
H" myeloma belonged to the first type while "Mrs W" IgG was 
apparently of the second, and contained some soluble aggregates.
The reason for the differing behaviour of the two preparations
was not obvious. The aggutinability did not relate to either the
overall charge (measured by starch block electrophoresis) or to 
four immunoglobulin allotypes (two Gm and two Km) (Morse, 1965).
The knowledge that "Mrs H" myeloma was Glm (f) negative while
"Mrs W" was Glm (f) positive (see Chapter 6) reinforces this finding.
6. Immune complex tests.
Anti-complementary activity (ACA) was measured by the Immunology 
Department, Royal United Hospital, Bath. Determination of % Clq- 
binding activity was carried out at the Blood Transfusion Service 
at Bristol, using the method outlined by Zubler and Lambert (1977).
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7. Other serological tests.
Levels of C3 and C4, and IgM RF titre (Direct anti­
globulin test) were kindly carried out by the Immunology Department, 
Royal United Hospital, Bath.
8. Statistical analysis.
Statistical significance was tested for by the Students 
t-test, using the small sample method for estimating the standard 
error after the variance ratio test had been performed. The 
t value was also calculated from a correlation coefficient. 
Chapters 13 and 16 of M.J. Moroney's "Facts from Figures" (1965) 
were used as a guide throughout this analysis.
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CHAPTER THREE SEPARATION OF CELLS
Introduction
The isolation of leucocytes from human peripheral blood by 
density-gradient centrifugation techniques has largely superseded 
that of dextran sedimentation in which yield and purity were poor 
(Hjorth, Jonsson and Vretblad, 1981). The use of Isopaque-Ficoll 
to isolate the mononuclear cell fraction as perfected by Boyum 
(1974, 1977) has been extended to that of granulocytes (English 
and Andersen, 1974; Boyum, 1976) and monocytes (Gadeburg,
Rhodes and Larsen, 1979), but the procedures involved may be 
lengthy(Pretlow and Luberoff, 1973; Loos and Roos, 1974; Loos 
et al., 1976a).
Concurrent to Boyum's work was that of Pertoft, who 
developed a colloidal silica sol coated with polyvinylpyrrolidone 
as a density-gradient medium (Pertoft, Back and Lindahl-Kiessling, 
1968; Pertoft et al., 1977). This is now marketed under the 
trade name of 'Percoll' by Pharmacia Ltd, and has
proved to be very versatile in allowing the isolation of particles 
ranging from viruses to macrophages (Pharmacia Ltd. literature), 
of lymphocytes and monocytes (Gutierrez et ai., 1979; Pertoft 
et ai., 1980; Gmelig-Meyling and Waldmann, 1980), granulocytes 
(Segal, Fortunafo and Herd, 1980) and eosinophils (Gartner,
1980).
This medium was thus considered in order to harvest both 
monocytes and granulocytes from the same sample of blood: a 
bi-farious procedure was developed. This involved the use of 
a two-step gradient to effect the dissociation of granulocytes
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from mononuclear cells, followed by sedimentation of the lympho­
cytes from the latter through a cushion of less dense Percoll.
Materials and Methods.
Choice of centrifuge tube;
All gradients and subsequent washes were performed in round- 
bottomed, screw-cap polycarbonate tubes (Nunc) to minimize cell 
adlrerence. This material was chosen because cultured cells 
have been shown not to adhere to polycarbonate suspension culture 
vessels (Cook, Counter and McColley, 1976), and unlike poly­
propylene does not have the disadvantage of being opaque.
Centrifugation of gradients was carried out in a temperature- 
controlled Mistral 6L centrifuge (MSE) at 18°C, and washes in 
a Heraeus-Christ 6000 bench centrifuge.
Preparation of gradients.
Percoll, purchased from Pharmacia (Great Britain) Ltd., 
Middx., was prepared as follows:
The stock solution of Percoll has a density of 1.130 ± 0.005 g ml
Nine parts of this were mixed with 1 part of lOx PBS to give
the working solution (WS), which was further diluted in IxPBS
to give the required densities, which were determined using a
“Itorpedo-shaped hydrometer graduated from 1.050 to 1.100 g ml 
(Baird and Tatlock). These agreed closely with those calculated 
from the known densities of the buffers and stock Percoll 




Two-step gradients were generated as follows:
2 mis of the denser of the two solutions (designated Y) 
were pipetted into a polycarbonate tube which was held upright 
in a clamp. A rubber collar or metal clamp was attached to 
the barrel of a 2 ml plastic syringe on which was a Gauge 21 
needle, so that when inverted the syringe would rest inside 
the tube with the needle-point just above solution Y (Figure 
3.1). 1.6 mis of the lighter solution X was drawn into the
syringe which was then inverted, as the plunger was removed, 
into the tube. The upper layer of the gradient formed without 
disturbance of the lower, and could be left while other 
gradients were generated in the same way.
Use of gradients.
Citrated peripheral blood diluted 3 in 5 with iso-osmotic 
PBS could then be layered on top of solution X, using a 
Pasteur pipette that had previously been angled in a Bunsen 
flame (Figure 3.1). The filled tubes were spun at 400 g for 
25 mins, and the cells at the two interfaces harvested by 
aspiration from above with an ordinary Pasteur pipette. Those 
from the upper layer were washed once in PBS containing 0.2% 
Egg Albumin (PBSÀ) (at 400 g for 10 mins.), and resuspended 
in 1 ml of this, to be layered onto a 2.5 ml cushion of a less 
dense Percoll. This was subjected to 750 g for 30 mins., 
and the interface cells collected. In some cases the pelleted 
fraction was also processed.
Legend to Figure 1.
The procedure for preparing a two step gradient of
Percoll.
Illustration A: Polycarbonate tube held vertical
in a clamp, and containing 2 mis 
of the denser solution Y.
B: A 2 ml plastio syringe with a
small clamp around upper part, 
and containing 1.6 mis of the 
lighter solution X.
C: The very end of a pasteur pipette
is allowed to bend over the gentle 
flame of a Bunsen burner.
D: The clamp around the syringe allows
it to rest in the tube, the tip of 
the needle just above the surface of 
Y, and against the wall. Solution X 
flows in freely without disturbing Y.
E: By the same principle, the blood/
buffer mixture can be layered onto the 
gradient with the tip of the curved 











All fractions were washed thrice in PBSA before being re­
suspended in the appropriate medium and counted. Cytocentrifuge 
smears were prepared for differential counts.
Use of an alternative method.
In some experiments the separation of granulocytes from 
mononuclear cells was carried out using Ficoll-Paque (Pharmacia) 
according to the method of Boyum (1974), and the contaminating 
erythrocytes lysed by exposure to buffered ammonium chloride, 
as detailed in Section 2.1.
Isolation from synovial fluid.
Granulocytes were also isolated from synovial fluid as follows,
The synovial fluid was taken into preservative-free heparin
(125 U per 10 mis.). Hyaluronidase (Sigma) was added to the
ofluid at 0.3 U ml and allowed to react at 37 C for 30 mins. 
(Froland, Natvig and Husby, 1973), after which the fluid was 
diluted with an equal volume of PBS and layered onto Ficoll- 
Paque (Pharmacia). For the sake of comparison, the peripheral 
blood was also heparinized, diluted volume for volume with PBS 
and separated on Ficoll-Paque as mentioned above. The
pellet below the Ficoll was washed once and the erythrocytes 
lysed with buffered ammonium chloride. The synovial fluid 
granulocytes did'not always require this treatment. The 
granulocytes were washed a further twice before being resuspended 
in M 199 plus 10% heat-inactivated foetal calf serum.
Trisodium citrate was employed as the anti-coagulant in
63
all but the above separation because the monocytes were found 
to clump less than vAien heparin was chosen. This finding has 
also recently been published by Brandslund et al. (1982) who 
noticed a marked aggregation bf thrombocytes, with monocyte 
involvement, in the presence of heparin.
Results
For the first stage, that is the two-step gradient, the 
dilutions of the working solution of Percoll which proved to 
be the most useful were 65% for solution X (density 1.083) 
and 76% (€= 1.096) or 77% ( ̂ ^ 1.097) for solution Y. Further 
experimentation showed that the yield was better with the 
latter (Figure 3.2) (78% against 62%).
This gradient gave a mononuclear cell layer free of all 
granulocytes save for an occasional myelocyte, and a neutrophil 
layer containing a few eosinophils.
The separation and cell yield was similar for both normals 
and patients suffering fran rheumatoid arthritis. Erythrocyte 
contamination of the granulocyte layer was variable and higher 
in the patient group but acceptable since treatment with 
buffered ammonium chloride for ten minutes between the first 
and second washes effected their removal.
The viability of all cell types, as measured by trypan 













76(1.096) 77(1.097) % (e)Percoll
Figure 3.2
The yield of neutrophils gained by using two different 
Percoll densities.
Results expressed as mean ±  one standard deviation, 
with the number of samples in brackets.
The difference between the two groups was not signif­
icant.
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For the second stage of cell fractionation, a cushion of 
52% Percoll (c. 1.068) was chosen as recommended by Carter 
(Pers. Commun.). The supported layer contained between 50 and 
100 percent monocytes (as judged by their morphology) and the 
pellet 80 - 100 percent lymphocytes. After the subsequent washes, 
the viability of the monocytic cells was in the order of 95% 
and the average yield 78% of those present in peripheral blood.
A differential count was always performed and the cells suspended 
to a constant number of monocytes per ml of medium.
A summary of the technique is given in Figure 3.3.
Discussion
The method described for isolating granulocytes has been 
used regularly for over two years and has consistently given 
good yields and pure preparations with high viability. The cells 
have been shown to be able to release free oxygen radicals and 
to be reactive in phagocytosis assays.
This method is very similar to that recently published by 
Hjorth, Jonsson and Vretblad (1981), although there is a diff­
erence between the densities of Percoll chosen for the separation, 
The density chosen by Hjorth et al. to isolate the mononuclear
cells (equivalent to Solution X in Figure 3.1) was the same
-1as that of Ficoll-Paque (1.0776 g ml ) whereas the protocol 
outlined in this chapter required a density of 1.083. The medium 
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Scheme for isolating cells.
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different density, in this case less dense than Hjorth's; 1.097 
compared to 1.1026. Tube size and g forces were similar. The 
reason for these differences is unclear. Some experimenters , 
including those mentioned above, advise the layering on of 
whole blood (Pertoft et al., 1980; Hjorth, Jonsson and 
Vretblad, 1981) while others, including Boyum (1976) advocate 
dilution with buffer, a procedure followed here. Fractionation 
behaviour has been reported to vary with the haematocrit of the 
blood applied (Pertoft et al., 1980); this dilution step may 
therefore be an important factor in rationalizing the different 
conditions.
Another procedural difference was that while the stock Percoll 
was made isotonic by dilution with ten-times PBS as suggested by 
Pharmacia (Percoll, methods and applications), Hjorth and 
colleagues added solid sodium chloride to the Percoll. Even 
slight changes in tonicity can drastically alter cell separation 
(own observations, unpublished) and should therefore be con­
sidered of importance.
Gartner (1980) has combined dextran sedimentation with 
a five-step gradient to isolate eosinophils in addition to 
neutrophils and mononuclear cells. The need for an ultracentri­
fugation step has. also been circumvented by Segal, Fortunate 
and Herd (1980) whose method utilizes a perspex gradient mixer 
to combine the blood and Percoll. All have found a high 
viability and integrity of cellular function after isolation 
using Percoll. Pertoft and his colleagues (1977) incubated
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cultured cells in various density gradient media and found that 
Percoll has little effect on the growth characteristics even 
after 100 hours, and much less so than did Picoll.
The decreased separation of erythrocytes from granulocytes 
in rheumatoid patients' blood, noticed in this study, has also 
been recently reported by Ferrante et al, (1982). This group 
of workers found it advantageous to alter their separation 
media accordingly. This approach was not considered necessary 
since very few samples did not separate well enough to be 
processed.
The densities of monocytes and lymphocytes overlap con­
siderably,so that the recovery of the two types on Percoll (or 
Ficoll) can suffer from cross-contamination, a phenomenon which 
seems to be donor-dependent (Gmelig-Meyling and Waldmann, 1980; 
Pertoft et ai., 1980). The purity and yield gained with the 
52% Percoll was comparable with that found by Gmelig-Meyling 
and Waldmann (1980) and by Brandslund et al. (1982); lower 
yields but higher purity were experienced by Pertoft (1980).
The density of the separation medium was similar in all cases. 
The combination of buoyant density centrifugation with adherence 
to glass or plastic may give a yield as low as 9% (Gadeburg, 
Rhodes and Larsen, 1979) without a concomitant increase in 
purity (24%). However, pre-coating of plastic petri-dishes 
with foetal calf serum prior to allowing adherence of mono­
nuclear cells, as developed by Kumagai and co-workers (1979), 
followed by detachment with a chelating agent, is capable of
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giving much higher purity (96%) and yield (54%).
The use of such additional methods makes comparison of 
the monocytes with the neutrophils from the same blood sample 
more difficult. Primarily, the additional technique may alter 
the functional capacity, or the surface, of the cell; secondly, 
the use of multiple techniques within the purification procedure 
may lead to decreased cell responsiveness because of the increased 
time factor before use. This is especially true for neutrophils 
(Ferrante, Beard and Thong, 1980) which have to be kept until 
the monocytes have been purified.
The mononuclear cells can be contaminated by myelocytes 
and myeloblasts, as noted by Boyum (1976). In normal controls, 
this is unimportant; they were occasionally found in prepara­
tions from rheumatoids, kxit never more than one percent.
This method was designed to subdivide peripheral blood 
leucocytes so that both a monocyte-enriched and a granulocyte 
population could be studied in parallel. It has proved to be 
functional and effective.
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CHAPTER FOUR. PHAGOCYTOSIS I; THE CHOICE OF STIMULUS AND ASSAY 
SYSTEM WITH A VIEW TO MEASURING PHAGOCYTOSIS.
Introduction
It was decided to study the properties of the peripheral 
blood phagocytes because of their importance in inflammation.
It is known that exocytosis occurs during the phagocytic event 
if the stimulus is large or surface bound because this cannot 
be fully phagocytosed (Henson, 1977; Treadway et al., 1979).
This phenomenon is a useful tool in the measurement of phago­
cytosis. The effects of both soluble and insoluble heat- 
aggregated IgG have been studied extensively (Henson, Johnson 
and Spiegelberg, 1972; Henson and Oades, 1975; Treadway et al., 
1979), as have precipitated and soluble immune complexes 
(Ward and Zvaifler, 1973a and 1973b; Turner et al., 1975;
Earners, 1980); these aspects are elaborated upon in the 
discussion of this chapter and in Chapter 6. Three particulate 
and two soluble compounds were chosen as possible agents to 
cause degranulation and their suitability compared.
Phagocytic cells contain a wide range of lysosomal enzymes 
(Bretz and Baggiolini, 1974; Nathan,Murray and Cohn, 1980;
Segal, Dorling and Coade, 1980) which can be assayed spectro- 
photometrically. The acid hydrolases can break down a p-nitro- 
phenyl or phenol-phthalein labelled substrate; myeloperoxidase, 
which may be located in a different azurophil granule to the 
acid hydrolases (Segal, Dorling and Coade, 1980) can be measured 
by its ability to oxidize 0-dianisidine. The cytoplasmic enzyme 
LDH is released on cell death, and is assayed by its mediation 




Heat aggregated human IgGl was prepared as described in
Section 2.3 as was soluble aggregate. Latex beads LBll, diameter
1.091 ± 0.0082 urn (Sigma) and carbonyl iron powder. Type SF
(GAF (GB) Ltd., Manchester) were not treated or washed prior
to use. Soluble complexes were partially purified from
rheumatoid synovial fluid (see Section 2.5 (iv)) and showed
an ACA of 1/512 in..the system used, at a protein concentration 
-1of 2.9 mg ml . A plasma containing soluble complexes were 
also studied, from a patient (initials B.C.) with RA and 
associated diffuse vasculitis who had an ACA of *2, IgM RF of 
1/512 and a Clq binding of 94.9%. Serum was generated from 
this by the addition of a three-fold excess of calcium and 
magnesium chloride (calculated with respect to normal plasma 
levels) . The clot was allowed to retract overnight at 4°C before 
the serum was harvested.
The granulocyte and mononuclear phagocytes were prepared 
by the method given in the previous chapter (Chapter 3) and 
were from apparently healthy donors unless otherwise stated. 
Monocyte enriched populations were not prepared during this 
part of the study. The phagocytic conditions have been set 
out in the 'Methods' fascicle (Section 2.3) and details of 
the enzyme assays are also given there in Table 2.1. The 
time course experiments were stopped by the addition of an 
equal volume of cold medium, so that the volume that was 
added to the enzyme assays was twice that of the usual. The 
amount of enzyme released was expressed as a percentage of the
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total in an unstimulated cell (LDH) or of that remaining in the
cell plus that released (acid hydrolases).
That is, if R = amount released
and Rm= remainder (cell lysate)
Then  ̂ , R x 100% released = --------Rm + R
Myeloperoxidase was expressed in terms of the equivalent activity 
of the standard horseradish peroxidase (Type II, 165 PGU; per mg 
solid. Sigma). Standards were employed for the acid hydrolases and 




The release of three different acid hydrolases was measured
-1in the absence of any stimulus and in the presence of 500 pg ml
of the aggregated IgG for both a granulocyte (PMN) preparation at 
6 —15 X 10 cells ml and a mononuclear cell (MNC) adjusted to 
5 X 10^ monocytes per ml. After one hour.* s incubation at 37°C, 
the background release of g-galactosidase ranged from zero to 65% 
for MNC (n = 5) and to 67% for PMN (n = 5), with the increment 
induced by stimulation varying between seven and forty-four percent. 
The exocytosis of boto acid phosphatase and B-glucuronidase was 
much less variable, and is shown in Figure 4.1. Each population 
of cells did not release equivalent levels of both enzymes. 
Lymphocytes alone did not release these enzymes (results not shown). 
A small number of experiments was carried out to assess the response 








300 5 0 0  U ff in l"^ H A G G
Figure 4,1
The response of phagocytes towards aggregated IgG (HAGG), 
measured by the release of lysosomal enzymes.Granulocytes 
were at 5 x 10^ ml  ̂ and monocytes at the same except for 
X and +  which were at 2 x 10^ ml” \  Incubation time was one 
hour at 37 C. Each value is the mean of duplicate samples.
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—1at 200 yg ml , and the latter at a latex:cell ratio of 10:1. This 
is detailed inFigure 4.2 which shows that neither particle promotes 
any enzyme release. One experiment was carried out with MNC and 
it also reflected this pattern.
The immune complex-containing IgG fraction from synovial fluid 
was compared with the myeloma IgG that had been passed through a 
Sepharose 6B-C1 column to remove aggregates, and also with HAGG.
A definite release of lysosomal constituents was noted in response 
to exposure to the synovial fluid IgG and this is shown in Figure 
4.3. Further, a comparison was made between this SF IgG, the 
HAGG,and soluble aggregate with both granulocytes and mononuclear 
cells, and the results are presented in Figure 4.4. Botli 
mononuclear cells and granulocytes responded to the SF IgG, but to 
a lower degree than to HAGG (.05 < P < .1 and P < .001 respectively).
Monocytes failed to degranulate in response to soluble aggregates 
(P < .001 cf. HAGG) while granulocytes responded poorly (P <  .001
of. HAGG). The difference in response to soluble aggregate and 
synovial fluid IgG was significant in monocytic cells (0.01 > P > .001) 
and approached significance with PMN (.1 > P > .05).
The use of a whole plasma that contained immune complexes, for 
a phagocytic assay, created two major problems . The plasma level 
of g-glucuronidase was much higher than the expected release from 
the cells. Once this background had been subtracted, any changes 
that might have occurred appeared negligible. If the plasma 
was diluted in tissue culture medium in order to diminish this 







Subject DJ BC LE TH
Figure 4.2
The release of ^-glucuronidase in response to stimuli, 
using granulocytes.
Open bars: the response of each subject’s cells to
500 jLig ml~^ HAGG.
Hatched bars:release in the absence of stimulus. 
Stippled bars: release with latex at 10:1 (latex:cell), 
DJ and BC only.
Vertical bars; release with carbonyl iron at 200 yig ml 
LE,TH and JV̂' only.









The release of p-^glucuronidase induced by synovial fluid 
IgG containing complexes, in comparison to the activity 
of monomeric and aggregated IgG,
No stimulus ^
IgG,1.25 mg ml  ̂ O
IgG,1.5 mg ml“  ̂ e
S.Fluid IgG,1.25 mg ral"^ v
S.Fluid IgG,1.5 mg ml  ̂ y
Aggregated IgG,1 rag ml”  ̂ ^
bach experiment was performed in duplicate on granulocytes
Figure 4.4.
The release of g-glucuronidase (background subtracted) 
in response to:
-T_
500 yg ml soluble aggregate (Sol Agg)
—1500 yg ml synovial fluid IgG (SF IgG)
—I200 yg ml heat-aggregated IgG (HAGG)
6 -1by mononuclear cells (1.25 x 10 ml monocytes) and
6 —Igranulocytes (5 x 10 ml ).
Statistical analysis;
All results are presented as mean ± 1 standard deviation, 
n = 6 for both HAGG and Sol Agg groups 
n = 5 for SF IgG group.
Pair MNC PMN
HAGG: Sol Agg P <  0.001 P< 0.001
HAGG: SF IgG 0.1 > P > 0.05 P< 0.001



























clot. Some of the plasma was, therefore, clotted before use as 
detailed in the Methods to this chapter. This serum was diluted 
from 100% through to 10% but none of the dilutions induced 
a measurable release of g-glucuronidase by granulocytes or mono­
cytes (two subjects). The same result was obtained when the 
cells were incubated in neat plasma (5 subjects). This treatment 
did not cause any cell death as assessed by trypan blue exclusion 
before and after the incubation period.
Lysosomal enzymes.
Since acid phosphatase and g-glucuronidase are both acid
hydrolases, it was decided to also follow the exocytosis of
-3peroxidase. This release was of the order of 10 purpurogallin 
units (PQJ) per 2.5 x 10^ cells per ml. The initial experiments 
suggested that the kinetics of release in this system were subject- 
dependent, but appeared to plateau by 20 mins for peroxidase while 
possibly still rising for g-glucuronidase release (Figure 4.5).
In further experiments with longer incubation times these possible 
differences were not consistently shown: Two patients with
RA and 2 normal controls were studied for both cell types (in 
duplicate) and for both of the enzymes, and representative data 
from granulocyte populations are shown in Figure 4.5. Subject 
N.F. showed a plateau for both enzymes, whereas the release crj- 
continued to rise with C.B. cells. The mononuclear cell prepara­
tions failed to respond with peroxidase release but did so with 
3-glucuronidase. The time course for this release was similar to 
that found for the granulocytes shown in Figure 4.5., except that 
the release tended to plateau between 5 and 15 minutes before rising 













A comparison of the release of two lysosomal enzymes in 
response to 300 ml~^ HAGG, over time.
Release of peroxidase a _ lateral ordinates, PGU x 10^/ml 












The response over 120 minutes of granulocytes exposed 
to 300 ml”  ̂ HAGG.
Release of peroxidase A p-glucuronidase A N . F . (control)
• O C .B.(patient)
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Discussion
Insoluble aggregated immunoglobulin G has been shown to 
stimulate the release of g-glucuronidase from neutrophils (Henson, 
Johnson and Spiegelberg, 1972), and this has been demonstrated 
here to be true for mononuclear cells as well as for granulocytes. 
Evidence suggests that soluble aggregates or complexes do not 
induce exocytosis (Treadway et ai., 1979; Lamers, 1980) but do 
stimulate the phagocyte's hexose monophosphate shunt (HMPS) activity 
(Henson and Oades, 1975). It was therefore not surprising that the 
complex-containing plasma did not induce a measurable degranulation.
An unexpected finding was that the "immune complex" rich IgG 
from synovial fluid should have caused a degranulation, albeit less 
marked than with HAGG (see Figure 4.4.). The preparation had 
been stored at -90°C for two weeks prior to use, but the plasma 
mentioned above had also been kept at this temperature. A further 
gel-filtration step followed by the immediate use of various fractions 
and determination of their ACA might have helped to elucidate the 
problem. It has proved difficult to correlate biological activity 
and size. McCarthy, for instance, has reported that aggregates 
of the same size, carefully isolated by polyethylene glycol 
precipitation and subsequent sucrose gradient, behaved differently 
in each of the three assays used for their detection (McCarthy 
et al., 1981).
Taichman, Pruzanski and Ranadive (1972) noted that a low, but 
variable, amount of degranulation could occur in the response of 
rabbit PMN to soluble albumin complexes, and this was found to be
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true for human PMN using soluble aggregates of IgG (Figure 4.4). 
Monocytes, however, did not release enzymes under these circum­
stances, which may reflect the general lower responsiveness of 
monocytes, even to HAGG, under the experimental conditions.
Uncoated latex beads can be taken up by polymorphs (Hallgren, 
Hakansson and Venge, 1978) but did not cause any degranulation 
under the conditions used here. Carbonyl iron powder has been 
used to deplete MNC of monocytes because the latter ingest it 
and so become more dense. They can then be separated frcxn the 
lymphocytes by density gradient centrifugation. No release of 
granular enzymes into the medium was noted vhen either granulocytes 
or MNC were exposed to carbonyl iron.
The acid hydrolases g-glucuronidase and acid phosphatase were 
both released in response to aggregated IgG, but a high release 
of one was not paralleled by the other. This suggests that the 
proportions of the two enzymes must be very different in either 
the granules of an individual cell or of the population as a whole. 
The higher background release of acid phosphatase, especially 
with MNC, meant that it was. less suitable for evaluating the 
response of the cells to a stimulus. Myeloperoxidase may be 
contained along with the acid hydrolases in azurophil granules, 
or may be situated in a different type of granule (see Chapter 1,
PMN leucocyte section). The release of peroxidase and g-glucuronidase 
seemed to parallel each other in these experiments. Measurement 
of a whole cell population is probably too insensitive a method to 
detect the difference in kinetics following phagosome fusion that
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Segal, Dorling and Coade (1980) have noted using isolated vacuolar 
fractions. Both monocytes and granulocytes are peroxidase 
positive vhen this is demonstrated histochemically (Yam, 1971); 
the unresponsiveness of some of the mononuclear cell preparations 
was therefore unlikely to be caused by a lack of the enzyme.
From the results gained it seemed reasonable to follow the 
release of g-glucuronidase as a standard measure of degranulation 
in response to aggregated IgG.
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CHAPTER FIVE PHAGOCYTOSIS II. COMPARISON OF THE LEUCOCYTES OF
r h e u m a t o i d  PATIENTS AND NORMAL CONTROLS
Introduction
Granulocytes and mononuclear phagocytes are important in 
inflammation, and for this reason the leucocytes from patients with 
rheumatoid arthritis (RA) have been compared with those from normal 
controls with respect to a number of parameters.
A defect in chemotaxis has been reported (Mowat and Baum, 1971) 
vhich seems to be attributable to the rheumatoid plasma (Walker,
James and Smith, 1979), and more specifically to immune complexes 
Kemp et ai., 1979; 1980). Howe and fellow-workers could not, 
however, confirm these results; only the RA subgroup of Felty's 
patients exhibited a decreased neutrophil migration (Howe et ai.,
1981). This was a cellular rather than a humoral phenomenon.
The migration of a whole leucocyte preparation could be inhibited 
by rabbit/human IgG complexes if the cells came from rheumatoids 
but not from normals (Hall, 1978). Howe also noted that there were 
no significant differences between normals, rheumatoids and Felty's 
patients with respect to the cells' adhesiveness to a nylon fibre 
column (Howe et ai., 1981). Leucocytes from RA patients do seem 
to bind extracts of rheumatoid synovium as assessed by leucocyte 
adherence inhibition (Tannenbaum, 197 9). Control cells were not 
affected.
The ability of monocytes to phagocytose bacteria (Bar-Eli et 
ai., 1980) and antibody-coated red cells (EA) (Temple and Loewi,
1977) was similar between patients and normals, although bactericidal
85
activity was diminished in cells fron patients (Bar-Eli et al., 1980). 
A defect in monocytic phagocytosis of serum-coated (that is complement- 
coated) , killed yeast, has been demonstrated in patients suffering 
from cutaneous vasculitis in addition to rheumatoid arthritis, but 
not in those with RA alone (Hurst and Nuki, 1981). Both fresh 
normal serum and complement increased the binding of EA whereas 
seven sera from patients with systemic lupus erythematosus (SLE) 
exhibited^inhibition. This was probably related to the presence 
of immune complexes (Temple and Loewi, 1977).
The uptake of IgG-coated latex by PMN has been reported to 
show a slight, but not significant, decrease for those from RA 
patients compared to normals (Hallgren, Hakansson and Venge, 1978) 
Yeast phagocytosis has been shown to be comparable (Turner,
Schumacher and Myers, 1973) vhen using peripheral blood neutrophils 
but decreased in those isolated from synovial fluid, vhether from 
rheumatoid or miscellaneous arthritides. Synovial fluids were 
less able to opsonize yeast for uptake than were sera.
More recently the secretory properties of peripheral blood 
granulocytes in response to zymosan were discovered to be the 
same in normals and in inactive patients who were receiving gold 
(van de Stadt, van de Voorde-Vissers and Feltkamp-Vroom, 1980),
Blood and fluid granulocytes from patients with active synovitis 
(about half of whom were receiving second-line 'anti-rheumatic 
drugs') responded similarly to each other though synovial cells 
released more LDH than those from blood. The group with active 
synovitis was not directly compared to the normal controls.
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It was decided to study the secretory capacity of both monocytes 
and granulocytes from patients with RA and from healthy controls. 
Aggregated IgGl was.used as the stimulus and g-glucuronidase as the 
indicator. Synovial fluid granulocytes were compared to those from 
paired peripheral blood samples in a separate study group.
Patients and Methods
The patients chosen had definite RA and at the time of bleeding 
had active synovitis. Eighteen out of 22 (82%) were seropositive by 
Rose-Waaler test and 10 of 22 (45%) showed some systemic disease 
such as nodules. One of these had definite Felty's syndrome, another 
possibly manifested this. The chemotherapy was confined to a wide 
range of non-steroidal anti-inflammatory drugs (NSAID) save for 
tlie possible Felty's patient who was taking 5 mg Prednisolone per 
day and a patient with pericarditis who v/as being treated with 
azathioprine. The duration of illness ranged from one to forty 
years, mean 12.4 ± 9.3 (± 1 Standard Deviation) and the age of the 
patients was from 33 to 75, mean 57.8 ± 11.3 years. There were 14 
females and 8 males.
A small group of patients used as "ill controls" were being 
treated with NSAID but did not have RA. One (61 yrs, 4 yr illness,
F) had severe osteo-arthrosis and four (IF, 3M) had ankylosing 
spondylitis (age 34 to 42, duration 13 - 20 years).
Synovial fluid studies were carried out on ten patients with 
RA with active synovitis. There \vere 6F and 4 M, ages 33 to 79; four 
were being treated with .'2nd line ' drugs in addition to NSAID (see
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Table 5.1). .
The control group were apparently healthy members of staff of the 
hospital. Their ages ranged from 22 to 61, mean 39.4 ± 14.0 and 
there were 12 females and 10 males. The controls for the drug 
experiment were made up of 4 F and 5 M, age range 25 - 42, and 
all were medical and scientific staff.
Methods.
The granulocytes (PMN) and monocyte-enriched cells (MEP) were 
prepared from citrated peripheral blood and synovial fluid granulo­
cytes from heparinized fluid as described in Chapter 3. Three patients' 
fluids and bloods were separated on Percoll (patients E.H., L.B., 
and G.M., Table 5.1). The peripheral blood granulocytes of one patient 
(E.G.) were treated with hyaluronidase after their second wash, at 
a concentration of 0.3 U ml ^ of the original blood volume, and 
then washed once. White cell and differential counts were always 
carried out to check for abnormalities.
The phagocytic assays were carried out as described previously;
6 -1with granulocytes at a concentration of 5 x 10 ml and the
6 -1 monocyte-enriched cells adjusted to 1.25.x 10 monocytes ml
The g-glucuronidase assessment was carried out as in Chapter 2 (Table
2.1). Each test was performed in duplicate and the mean taken.
Results.
The PMN and MEP preparations were exposed to concentrations of
-1the IgG aggregate which varied from 50 to 500 yg ml and compared
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with the release at zero concentration. This background level was
subtracted from each result which was then expressed as A% release
of g-glucuronidase; this was also done on all subsequent data
unless otherwise stated. Some subjects' cells were not challenged
with every concentration of stimulus. Figures 5.1 and 5.2 show the
results obtained for granulocytes and monocytes respectively. It
can be seen that there were significant differences found between
normals' and patients' granulocytes, the patient response being
less than that of the controls. The most significance p < .001
-1was found in the cells' response to 300 yg ml HAGG, controls 
releasing 24.6 ± 5.1% and patients 17.1 ± 3.6% glucuronidase 
(mean ± 1 S.D.). At all other aggregate concentrations tested, 
the differences had P values between 0.01 and 0.001.
The monocytes, however, behaved comparably overcthis time 
scale with no significant differences. It was found, as might be 
expected from the latter, that the degree of response of the two 
cell types did not correlate (for controls, r = 0.163, n = 22; 
for patients r = 0.268; n = 21).
Investigation of the difference.,
Because of the differences in ages of the two groups as.a
vAiole, regression analysis was performed for the two groups. Age
-1was compared with A% release at 200 yg ml HAGG, There was a 
slightly decreased release with age but this did not approach 
significance (r = -0.15 for both controls (n=32) and patients 
(n=32).
Legend to Figures 5.1 and 2 .
The release of g-glucuronidase in response to HAGG.
Ordinate: Release of enzyme with background (zero HAGG) 
value subtracted 
Abscissa: increasing concentrations of HAGG.
Results expressed as x ± 1 SD 
control group _0_ 
patient group 
Figure 1. appertains to granulocytes, 12 ^ n 4 22 
Figure 2 appertains to monocytes (MNC) 10 4 n ^ 22 
Statistical analysis, difference between patient and control 
groups;
HAGG PMN MNC
50 yg ml .01 > P > .001 not. sig
100 .01 > P > .OOl NS
200 .01 > P > .OOl NS
300 P < .001 NS
400 .01 > P > .001 NS





100 200 4 0 0  5 0 0  
ml  ̂ HAGG
300
Figure 5.1






3 0 0 4 0 0  
1ml HAGG
Figure 5.2
The release of ^ -glucuronidase by mononuclear cells.
See legend opposite Figure 1.
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There wâs the possibility that the drug therapy was causing 
the depression of response, and that in this case the monocytes 
were less sensitive to its effects than were the neutrophils. 
Therefore, the behaviour of the granulocytes from patients who 
did not have RA but were on NSAID therapy was investigated. With 
the five patients studied, there appeared to be a decrease but 
no significant differences were found between them and the other 
groups (see.Figure 5.3). In view of these results, it was decided 
to study the response of granulocytes from volunteers before and 
after 72 hours treatment with an anti-inflammatory drug. Soluble 
aspirin was chosen as the agent, at 600 mg tds. The control group 
consisted of 9 members of staff, three of whom did not complete 
the three -day course because of side-effects. The last dose 
was taken two hours before bleeding in those completing the course 
The details are given in Figure 5.4., and representative titres 
in Figure 5.5 (from three subjects who completed the therapy).
It was obvious that there was no overall alteration consistent 
with the difference that had been found between RA patients and 
controls.
The release by PMN in response to 200 yg ml  ̂ HAGG after the 
subtraction of background release was compared to the IgM RF 
titre and to the Clq-binding activity of each patient's serum. 
Regression analysis was employed. For the R.F. comparison, r 
equalled -0.229, and with n = 22, this was not significant. When 
comparing Cll-binding activity with enzyme release, however, r 
equalled -0.751 (n = 7, 0.05 < P < 0.1) i.e. possibly significant. 















The release of ^-glucuronidase in response to 
200 ml ^HAGG. by patient and control groups, 
-e- represents the mean and bars (-) ± 1 SD 
Controls to RA patients .01^ P >  .001 








PRE POST KSAID treatment 
(72 hrg.)
Figure 5.4
The effect of aspirin therapy on the responsivnes: 
of granulocytes to 200 yjg tnl”  ̂ HAGG.
The administration ceased at 24 hours
3 6 hours 
6 0  hours A
See also Figure 5» for varying concentrations 
of aggregate.
Figure 5.5.
The effect of aspirin therapy on the responsiveness of 
granulocytes to aggregated IgG.
Blood samples were taken before (^ ) and after (O )
72 hours of aspirin administration, and each cell 
preparation was exposed to increasing concentrations 
of HAGG.
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Synovial fluid granulocytes.
The response of granulocytes from paired peripheral blood and 
synovial fluid was investigated in a group of patients with active 
RA and effusions of the knee. The synovial fluid PMN had a viability 
of between 91 and 99% after they had been isolated, ccrapared with 
a greater than 99% viability by trypan blue exclusion for their 
counterparts from the blood. The percentage LDH release values 
were 2.4 to 9.6 and 1.0 to 6.2 respectively. Hyaluronidase treat­
ment did not decrease the viability of the cells (1.0% compared 
to 3.3% for untreated PMN, one patient).
Each cell type was exposed to varying concentrations of HAGG and 
the difference in response between the blood and fluid cells was 
determined. The results are shown in Table 5.1: there were no
consistent differences between peripheral blood and synovial fluid 
PMN. The changes did not correlate with the drug treatment of the 
patients, nor with their serum IgM RF titre. Clq-binding estimations 
of blood and fluids were not carried out. The hyaluronidase treatment 
of peripheral blood granulocytes decreased their response to lower 
levels of aggregate but notbthe, same extent as was found for the 
fluid leucocytes. Viability was not decreased (Table 5.1).
Discussion.
Of the cells studied in these degranulation experiments, it was 
the granulocytes from blood that in the RA group as a whole reacted 
differently to the normals in that they released less % g-glucuronidase 
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to the Clq-binding activity in the sera of the patients. Although 
chemokinesis of peripheral blood neutrophils is not apparently 
affected by the serum immune complexes (Kemp et al., 1980), the 
uptake of sensitized sheep red blood cells by human monocytes is 
definitely inhibited by inclusion of immune complex-rich serum in 
the in vitro incubation (Temple and Loewi, 1977). The possibility 
of phagocytosis of immune complexes occurring in the blood stream 
is much less than that in the tissues because granulocytes need 
a surface on which .to crawl. Indeed, one study failed to demonstrate 
intracytoplasmic inclusions of IgG, IgM or C3 in blood leucocytes 
frcm seapositive RA patients, while showing their presence in SF 
leucocytes (Cats, Lafeber and Klein, 1975). Vaughan discovered 
inclusions in the SF leucocytes of 15 RA patients, six of whom also 
exhibited them in their PB leucocytes, though less strongly than 
those from the fluid (Vaughan at ai., 1968). Immunofluorescence 
was used for both studies. In the absence of paired immunofluore­
scence and degranulation data, it is impossible to tell whether the 
presence of immune complexes has any bearing on the ability of the 
phagocytes to react to the IgG aggregate.
The studies that have found similar behaviour of normal and 
patients' PMN have involved complete uptake of latex (Hallgren, 
Hakansson and Vengé, 1978) and yeast (Turner, Schumacher and Myers, 
1973) rather than the frustrated phagocytosis employed in the 
system described in this chapter. This may be an important variance.
The diminished ability of patients' granulocytes to respond 
to the phagocytic stimulus did not appear to be related to either
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age or drug therapy. Herzer and Lemine1 (1980) have shown that NSAID 
only inhibit phagocytosis of latex and cell activation by dextran 
sulphate vÈien the drug is present in the incubation medium, and 
that at a concentration five ..times that of in vivo levels. Pre­
incubation of the cells followed by washing abrogated this effect.
Kemp noted that the ability of neutrophils from peripheral blood 
to respond to a chemotaxin was in fact increased in RA patients 
taking aspirin compared to a group who were not doing so (Kemp 
et al., 1980). In the same study, he ascertained that the degree 
of chemokinesis could not be correlated with serum immune complexes 
as measured by Clq-binding as mentioned above. However, synovial 
fluid PMN chemokinesis was depressed to an extent inversely 
related to the joint fluid complex level. In the study described 
here, there was no consistent difference in the reacitivity of 
fluid PMN towards the phagocytic stimulus as compared to that of 
peripheral blood granulocytes. The slightly increased LDH release 
agrees with the findings of Van de Stadt and colleagues (1980).
If there is an inherent defect in the granulocytes of RA 
patients, it is not manifest in the circulating monocytes. The 
results suggest that there is no difference in the phagocytic 
response that leads to degranulation between those cells from patients 
with RA and control volunteers. This agrees with the findings of 
Bar-Eli and colleagues (1980) who did, however, demonstrate a 
decreased bactericidal activity in patients' cells, a property 
not tested in this study. Fc-mediated phagocytosis has been shown 
to be the same in RA's and normals' monocytes by Hurst and Nuki 
(1981). The similarity of response may reflect a genuine identity
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with normal mononuclear phagocytes, or the fact that since the 
circulating cell is not fully developed in its secretory properties 
(Bennet and Cohn, 1966) the difference has not yet become evident. 
This question might have been clarified by incubating peripheral 
blood monocytes for 24 to 72 hours in the presence of aggregate, 
with regular sampling for g-glucuronidase release. Alternatively, 
they could be cultured in its absence and subsequently challenged 
with the stimulus.
Degranulation is only onepart of the phagocytic process (see 
Chapter 1, including Figures 1.2 and 1.3). In view of the differences 
between cells noted in the experiments detailed here, some other 
aspects were also studied. The findings are presented in Chapters 
7 and 8 of this thesis.
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CHAPTER SIX THE MODULATION OF PHAGOCYTOSIS
Introduction
The degree of phagocytosis of particles can be altered by the 
presence of molecules such as complement, rheumatoid factors and 
immune complexes.
The opsonization of particles such as zymosan with the 
complement component C3 greatly enhances their ability to stimulate 
phagocytes, more so than does coating with just IgG (van de 
Stadt, van de Voorde-Vissers and Feltkamp-Vroom, 1980). When 
C3 interacts with IgG or IgM-containing immune complexes 
(anti-DNA/DNA), their growth into large complexes is inhibited, 
but when the complexes contain only IgM anti-DNA the presence 
of C3 is necessary for their processing by monocytes (PMN 
processing is absent). The same researcher has reported that 
the molecule Clq increases the size of small IgG anti-DNA/DNA 
complexes, but has no detectable effect on the IgM-complexes 
(Lamers, 1980). In contrast, it seems that Cl is able to 
inhibit IgM RF - mediated agglutination of IgG-coated latex 
and even distintegrate pre-formed agglutinates (Hallgren,
1980).
The effect of immune complexes on the phagocytosis of 
other particles is one which appears to be solely cell-dependent. 
The observation that their ingestion can diminish subsequent 
phagocytosis (Turner, Schumacher and Myers, 1973) has already 
been discussed in Chapter 5.
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In terms of the behaviour of rheumatoid factors, any alter­
ation in the ingestion of immune complexes by monocytes and 
granulocytes appears to be directly attributable to their 
shifting the equilibrium from soluble to insoluble complexes, 
and vice versa (Ward and Zvaifler, 1973b; Turner et al. 1976; 
Treadway et al., 1979; Lamers, 1980; Lamers, de Groot and Roos,
1981). In vitro, IgM RF has been shown to increase the amount 
of free antigen in pre-formed immune complexes (Alkner and 
Hansson, 1979). However, RF has been reported to alter the de­
granulation of neutrophils in response to surface-bound aggre­
gated IgG (Timms, Johnson and Henson, 1975), a process which 
is unlikely to involve equilibrium effects. The authors 
stressed its complement independence, and its possible importance 
in the role of IgM RF as a protective agent in rheumatoid arthritis 
(Timms, Johnson and Henson, 1975).
These three variables were investigated, making use of the 
degranulation in response to aggregated IgG that has been described 
in previous chapters.
Materials and Methods
The granulocytes and monocytes were isolated from peripheral 
citrated blood by the method detailed in Chapter 3 (see Figure 
3.3). Monocyte-enriched populations were used for the rheumatoid 
factor experiments, and mononuclear cells for all others. The 
details of the purification and aggregation of IgG; the isolation 
of rheumatoid factors and of putative complexes from synovial
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fluids and the preparation of anti-immunoglobulin allotype 
reagents have been laid out in Chapter 2, section 5. The 
plasma sample D.C. that contained complexes was the same as that 
used in Chapter 4. All normal sera used were ACA negative and 
had normal levels of CH^^, C3 and C4.
1. Complement experiments;
Normal serum was decomplemented either by heat inactivation 
at 56 C for 30 minutes or by inulin streatment, as used by 
Lamers (1980). Briefly, inulin from Dahlia tubers (Sigma) was
washed twice in distilled water (5000 g 10 mins). Normal human
serum was incubated for two hours at 37°C with the washed 
inulin at 50 mg ml , then the latter was removed by centri­
fugation for 20 minutes at 5000 g. The CH^^ after these treat­
ments was negligible, being less than 10 units compared to the 
350U found in untreated serum. Complement coating was carried 
out by incubating the aggregated IgG with 2.5, 5 or 10% normal 
serum for one hour at 37°C followed by storage in crushed ice, 
for up to two hours, until required. The decomplemented sera 
were used as control incubations. The coating with 10% serum, 
for instance, became a 0.25% serum concentration when the 
aggregate, iwas added to the cells. The aggregate concentration
— 1 ^ — I 0 —was 100 yg ml , PMN were at 5 x 10 ml and MNC at 1.25 x 10 ml 
(monocytes). The cells were from normal controls for these 




Pre-incubation of phagocytes was carried out in the complex-
containing plasma D.C. vol/vol with M 199, or in M 199 plus
10% FCS, for 45 minutes at 37°C on a rocking table. Each tube
was centrifuged at 150 g for 10 minutes and the supernatants
discarded; the pelleted cells were washed once in PBS. The
-1appropriate stimulant (medium or HAGG at 200 y g  ml ) was added 
to the cell pellet in 250 yl of medium and incubated for a further 
45 minutes at 37°C. Centrifugation at lOOO g for 10 minutes 
followed this, and the supernatant was harvested. The pellet 
was lysed with BSA/Triton and centrifuged (see Chapter 2). The 
viability of the cells was estimated by trypan blue. Two 
subjects (E.C. and A.F.) vere rheumatoid patients and two were 
normal controls (J.W. and P.S.).
3. Rheumatoid factor experiments:
The phagocytosis assays were identical to that described 
in Chapter 2, save for the addition of the appropriate concen­
tration of purified rheumatoid factor and correspondingly less 
tissue culture medium. Two preparations of rheumatoid factor were 
used; a purified IgM RF kindly donated through Dr. P.M. Johnson, 
University of Liverpool and a mixed IgM-IgG RF that was given 
by Dr. C. Elson, University of Bristol. The latter preparation
contained 29% IgM RF and 71% IgG RF, as measured by radio-immuno­
assay, and was given the abbreviation MxRF (mixed rheumatoid
factor). The IgM RF had a protein concentration of 700 yg ml ^
“1with a latex titre of 1/40; the MxRF at 2.5 rag ml titred
-1to 1/2560 (equivalent to 1/160 at 700 yg ml ). Monocytes were 




When fresh or heat-inactivated sera were allowed to react 
with HAGG prior to the addition of the cells, an alteration 
in the cellular response was seen when compared to HAGG in 
buffer alone (Table 6.1). This change was very dependent upon 
the person, but in some increased slightly with increasing fresh 
serum concentration, but less so with heat-inactivated serum.
In some subjects (J.F. and S.W.) the monocytic activity seemed 
to be inhibited by fresh and HI serum while in others (R.E. 
and A.R.) it seemed to be stimulated inboth. Decomplementation 
with inulin did not alter the level of response of PMN and the 
single result with monocytes suggested the same. These experiments 
showed that under the conditions used, the fixation of complement 
ty HAGG had no unipolar effect on degranulation by monocytes or 
by granulocytes.
In the absence of heat-inactivated FCS, the release by PMN 
was less than in its presence (Table 6.2), and this reflects the 
result found with human serum, despite the differences in final 
serum concentration. This foetal calf serum had no demonstrable 
CH50 activity.
5. Experiments with complexes;
The viability of both monocytes and granulocytes was not 
affected by incubation in plasma D.C. v/v M 199 or M 199 with 10% 
FCS (viability was at least 99%), and this did not decrease with 
a second incubation. Despite this, the background release from 
the cells was higher than usual, whether preincubation had taken
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Serum
2.5%F 5%F 10%F 2.5%HI 5%HI 10%HI
MNC
R.E. 1.23 2.32 1.59 2.86 2.73 2.68
A.R. 1.86 1.18 0.98 2.16 1.95 2.05
J.F. 0.56 0.80 0.78 1.05 0.88 1.07
S.W. 0.60 0.43 0.82 0.63 0.74 0.64
PMN
R.E. 1.04 1.12 1.59 0.98 0.70 1.11
A.R. 0.70 1.15 1.04 0.79 0.92 0.96
J.F. 1.04 1.13 1.50 1.32 1.18 1.48
S.W. 1.00 1.10 1.10 0.94 1.02 0.65
Serum
25%F 25%HI 25%I
MNC M.K. 1.14 1.64 1.10
PMN M.K. 1.37 1.28 1.19
S.F. 1.33 1.31 1.27
L.D.H. values; MNC zero - 11.3% PMN 0.7 - 13%
Table i6.1. The effect of coating aggregated IgG with serum treated
in different ways •
Key: F Fresh human serum HI heat-inactivated serum
I inulin-treated serum
Each value is the mean of duplicate tests, calculated using the
following equation: release HAGG+additive - additive alone
release (3-glucuronidase) release HAGG+buffer - buffer alone
HAGG , -1 yg ml
50 200 500 Table 6.2. The effect, of








16.0 calf serum on the release
B.C. of 3-glucuronidase by
+FCS 6.3 18.1 23.3 PMN.-FCS 5.2 10.6 14.5
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place in medium or plasma (9.0 ± 5 . 5  (n = 8) for double incubation, 
3.7 ± 2.9 (n = 8) for the single). Allowing for this (Table 5.3), 
the response of preincubated cells was in all but one test (E.C. PMN) 
less than that from cells treated only once (that is, no pre­
incubation) . Where the phagocytes had been exposed to plasma
D.C. rather than to medium, they were less able to respond to 
—1
200 yg ml HAGG, in 3 out of 3 MCP and 2 of 4 PMN preparations.
6. Experiments with rheumatoid factors:
Monocyte-enriched and granulocyte preparations were allowed 
to react with aggregated IgG with and without various concen­
trations of the MxRF. The MxRF alone induced no significant 
degranulation, being on average 0.8% for MEP and 1.2% for PMN.
The results were expressed as the release above background of 
3-glucuronidase in the presence of HAGG plus the RF, divided 
by that in the presence of HAGG alone. A figure of less than 
unity, therefore, represents inhibition, and more than one 
describes stimulation of degranulation by the RF. It can be 
seen (Figure 6.1) that an increasing concentration of MxRF 
caused a progressively greater inhibition of degranulation by 
monocytes, but not by PMN. These latter cells were, if anything, 
slightly stimulated. Patient and control cells behaved comparably, 
so the data for the two groups was pooled.
When a similar experiment was carried out using the pure
IgM RF, a different pattern of behaviour was seen (Figure 6.2). This
protein had a minor inhibitory effect on monocytes, even at 
—150 yg ml , while at the same concentration the MxRF was very 
active. The difference between the two was significant ,
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Mononuclear cells








E.C. 1.5 12.8 11.3 1.4 4.7 3. 3
J.W. 3.8 17.0 13.2 6.1 10.7 4. 6
A.F. 8.7 16.2 7.5 1.9 13.6 11.7
P.S. 5.7 12.5 6.8 0.6 10.1 9, 5
Pre-incubation with M 199 + 10% FCS
E.C. 13.4 20.3 6.9 3.5 9.0 5. 5
J.W. 20.5 30.5 10.0 6.9 6.7 -0.2
A.F. 9.5 14.5 5.0 3.8 13.1 9,,3
P.S. 6.3 ND ND 3.7 7.6 3.,9
Pre-incubation in D.C. plasma v/v M 199
E.C. 13.3 16.3 3.0 8.6 9.2 0,.5
J.W. 20.1 18.6 -1.5 11.1 11.8 0,.7
A.F. 7.3 9.6 2.3 4.7 10. 3 5,.6
P.S. 7.8 12.8 5.0 3.6 9.3 5,. 7
Table 6 .3 The effect of pre-incubating cells in a plasma with
a high Clq-binding (D.C. plasma), or in M 199 plus
10% Foetal calf serum, prior to challenging them with 
-1
200 yg ml of HAGG.
Each value is the mean of duplicate tests, and is 
% 3-glucuronidase released.
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Figure 6.1
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Figure 6.2
T h e  e f f e c t  o f  d i f f e r e n t  r h e u m a t o i d  f a c t o r  p r e p a r a t i o n s  
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The effect of altering both rheumatoid factor 
and aggregate concentrations,
- 1Ù à B.M. HAGG at 50 juig ml
à A B.M. HAGG at 200 >ig ml
-1
- 1
■o S.%. HAGG at 50 jug ml
- 1•...• S.W. HAGG at 200 jug ml
Zero represents the maximum possible inhibition,
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0.05 > P >0.02. Neither preparation affected granulocyte function 
to any degree.
Both RF (mixed RF) and aggregate concentrations were altered
and some of the results for monocytic cells are shown in Figure 6.3.
In three cases the inhibition increased with MxRF concentration
whatever the aggregate concentration. However with S.W. cells in
response to 200 yg ml ^ HAGG tliere was a progressive inhibition
—1fran 10 to 40 yg ml of the rheumatoid factor followed somewhat 
unexpectedly by a rise in degranulation (see dotted line. Figure
— 16.3). This suggested that maximal inhibition occurred at 40 yg ml 
of MxRF. The behaviour of the polymorphs was not affected by 
changing the concentration of the aggregate (results not sho'/m) .
The mean LDH release fro the monocytes was 6.5% and.for granulo­
cytes 2.0%.
The pure IgM was again inactive when a chequerboard was 
tried (not shown). The mean LDH release for monocytes was 2.5% 
and for PMN was 5.5%.
Discussion
The effect of the rheumatoid factor was difficult to inter­
pret because of the'probable presence of self-associating complexes 
in the mixed rheumatoid factor preparation. The following experiment 
was designed to clarify the position. The allotypic marker Glm (f) 
li es at amino acid position 214 in the hinge of the IgGl molecule 
(van Loghem, 1978) and IgM antibody activity towards it is found
112
in a small number of Glm (f)-negative people. The Blood Transfusion 
Service (Southmead) were kind enough to donate some anti-Glm (f), 
and some Glm (f)-positive serum, and details of their purification 
are given in Chapter 2. The possible reactions between such an 
antibody and aggregated or free IgGl are shown in Figure 6.4. The 
phagocyte would be expected to respond identically to aggregated 
IgGl of either allotype, but upon the addition of the IgM fraction 
that contained anti-Glm (f) a difference in behaviour might occur 
between the two. Whereas the antibody would not react with 
Glm(f)-negative IgG, it would bind to the positive; it might mask 
antigenic sites on the IgG, or create new ones at the Fc end of 
the IgM. If free Glm (f)-positive IgG were to be added, then 
soluble complexes might form with the antibody and be taken up 
by the phagocytes. The degranulation response towards aggregate 
might then be diminished. The use of Glm (f)- negative aggregate 
in this case abrogates the chance of the antibody reacting with it, 
and so increases the specificity.
These experiments would be directly comparable to the use 
of pure IgM RF and self-associated IgG/IgM RF with the added speci­
ficity gained by having an aggregate with which the antiserum cannot 
react. Unfortunately, it was not possible to bring these ideas 
to fruition because of the technical problems outlined below.
Purified Glm(f)-positive IgGl from normal serum or from 
a myeloma (Mrs W) did not aggregate to the same degree as did the 
IgGl used in previous experiments (Mrs H) which itself typed as 
heterozygous, the normal IgG being positive and the myeloma 
negative. The degree to which myeloma y-globulins aggregate on exp-
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Degranulation in response to 
aggregated IgGl, G1m(f) positive 
or negative.






A scheme illustrating the use of immunoglobulin allotypes 
towards an understanding of the action of rheumatoid 
factor.
Code: ^ ----- G1m(f) negative IgG
P G1m(f) positive IgG
 X  anti-Glm(f) Igfl
114
osure to heat has been discussed in Chapter 2, Section 5 (vii).
A Glm(f)-negative myeloma could not be found in the few locally
available. The antiserum had a titre of 1/4 by haemagglutination
prior to isolation of the IgM fraction when it dropped to h, at 2.5 
—Img ml . This activity was considered too low for definite
results. Anti-allotypic sera of high titre are less readily available
because of their use as routine reagents.
Owing to these problems, no insight could be gained into the 
modulating effects of RFs on phagocytosis by the use of allotypes.
Two types of rheumatoid factor were studied with respect to their 
ability to modulate the activity of phagocytes. A preparation that 
consisted of pure IgM RF had little effect on either monocytes or 
neutrophils (see Figure 6.2). In oontrast, the preparation that 
contained both IgG RF and IgM RF had a dose-dependent inhibitory 
activity upon monocytes (but none on granulocytes), as shown in 
Figures 6.1 and 6.2. These results with pure IgM RF and the mixed 
IgG/IgM RF suggest that the presence of the IgG RF mediates the 
change in IgM activity from having no effect on phagocytosis by 
monocytes to an inhibitory one. In vivo, this inhibition 
could lead to increased circulating complexes. Recently, Scott 
and colleagues (Scott D.G.I. et ai., 1981) noted that RA patients 
with vasculitis had a higher IgG RF level than did those with 
synovitis and also' Were more often ACA positive. The anti- 
complementary activity of serum correlates with the presence 
of immune complexes that contain IgG as the antibody and this is 
thought to be because IgM antibodies are somewhat labile, and this 
assay for complexes involves an incubation step of one hour at
IT
56^C (Johnson and Mowbray, 1977). This anti-complementary 
activity correlates too with the presence of vasculitis in 
pathological states, and within rheumatoid arthritis is partly 
characteristic of vasculitis. It is possible therefore that the 
presence of the circulating, complement-binding complexes is 
directly related to the presence of IgGRF(in addition to the IgM 
type), and this could be explained by the experimental findings 
that cells destined to becccne residents of the tissue mononuclear 
phagocyte system are made refractory towards aggregated IgG when 
both RF types are present.
Onyewotu and associates (1975) found that the presence of an 
excess of RF enhanced the uptake of soluble aggregates by guinea 
pig macrophages, but produced an inhibition when the aggregate 
predominated. The sera from vasculitic patients contained immune 
complexes that enhanced uptake of the soluble aggregate; the 
authors proposed that free valancies on the RF in the complexes • 
would take up the soluble aggregate and present it as a larger 
molecule to the cell. This would only occur if the RF already 
had some antigen binding sites full, for example in circulating 
immune complexes in vasculitis.
The phenomenon of enhancement-inhibition was not seen when 
the mixed rheumatoid, factor was used in the present experiments. 
Inhibition increased with the RF concentration (Figure 6.1). The 
purified IgM RF appeared to behave in a way opposite to Onyewotu's 
reagent, but not definitively (Figure 6.2). The difference in 
behaviour is most likely to be due to the varying size of the 
aggregates: the enlarging and precipitating effect of RF on
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soluble aggregates (with RIN, Turner et al., 1976 and with both 
PMN and monocytes, Lamers, 1980; 1981) would be negligible on 
a particulate aggregate.
The lack of effect on neutrophils would not be surprising, 
per se, since they do not express IgM receptors (Henson, 1977) . 
However IgM RF has been shown to inhibit the release of g-glucuron- 
idase from PMN responding to surface-bound aggregated IgG (Timms, 
Johnson and Henson, 1975) and to precipitated BSA/anti-BSA 
complexes (Ward and Zvaifler, 1973b) and this protective effect 
may be mediated by covering the stimulant with a protein that the 
neutrophil cannot bind (IgM). This change was not demonstrable 
using either the pure IgM RF or the mixed preparation (Figures 6.1 
and 6.2), although it is possible that a higher concentration of 
the IgM RF might have produced such an alteration. Lack of this 
reagent precluded further experiments being performed.
The interaction of neutrophils and aggregated IgG or 
precipitated BSA/anti-BSA complexes is thought to be complement 
independent, and this has been demonstrated in this study (Timms, 
Johnson and Henson, 1975; Ward and Zvaifler, 1973a and 1973b). 
Depletion of serum C1/C2 by heating or C3 by inulin treatment had 
no effect on the cellular response. If serum (either fresh or 
inactivated) was omitted, however, the cells responded less 
well (Tables 6.1 and 6.2). Which serum component(s) might be 
responsible for this was not investigated.
Previous ingestion of immune complexes can decrease the
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subsequent phagocytosis of yeast particles (Turner, Schumacher 
and Myers, 1973), even if the two stimuli are present together 
(Svensson, 1980). The same worker has also demonstrated that 
sera containing immune complexes can also do this, and this was 
demonstrated with the plasma D.C. The nigher background release 
after two incubation steps made interpretation difficult (Table
5.3), but preincubation in the plasma certainly seemed to have 
an inhibitory effect. The influence of immune complexes on sub­
sequent phagocytosis has already been discussed in the previous 
chapter. The increased background secretion of 3“glucuronidase 
was not apparently due to cell death (as assessed by trypan blue 
exclusion) although in the case of J.W. both cell types failed to 
respond to the challenge with HAGG, suggesting that they were 
not too healthy. LDH estimations were not carried out on this 
experimental group.
The action of these complexes and the rheumatoid factors 
needs to be investigated at a level that will measure the inter­
action of cells and stimuli without the need for degranulation.
The mixed rheumatoid factor preparation may be exerting an influence 
because of the presence of self-associated immunoglobulin (complexes) 
a process that cannot occur in the pure IgM RF because no IgG is 
present. Such complexes might be expected to cause metabolic 
stimulation of the cells, a phenomenon independent of exocytosis 
(Henson and Oades, 1975; Kitagawa, Takaku and Sakamoto, 1980b; 
McPhail, Henson and Johnson, 1981). This possibility is investi­
gated in a later series of experiments which are presented in 
Chapter Eight.
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CHAPTER SEVEN FURTHER STUDIES ON PHAGOCYTES: I. SURFACE RECEPTORS
Introduction
Phagocytic cells respond to a stimulus if they can recognise 
it/ and this is brought about through receptors in the plasma 
membrane. Neutrophils express receptors for chemotactic peptides 
(as previously indicated in Chapter 1 "Surface receptors on 
neutrophils") but possession of such receptors is not confined to the 
phagocytes. For instance chemotaxis is a property of very many 
non-fixed cells including bacteria and is obligatory for the 
formation of a fruiting body in the cellular slime mould Dictyostelium 
discoideum (Ashworth, 1973). Lymphocytes migrate to various parts 
of the lymphoid system in the presence or absence of antigen 
(Inchiey et al., 1976; Schlesinger, 1977), a property that is 
affected by treating the cell surface with enzyme. They possess 
different receptors according to the type of lymphocyte that they 
are; for instance, 'B' cells can bind the Fc region of IgG, and 
C3b (McConnell, 1976a). Mononuclear phagocytes and
neutrophils also possess these two receptor types (Ehlenberger 
and Nussenweig, 1977; Scott C.,1981), whereby they are able 
to bind to immune complexes, an ability which has been harnessed 
by immunologists. The association constants for the interaction 
of macrophages with radiolabelled complexes have given an indication 
the number, specificity and activity of surface receptors (Leslie
1980). The surface” distribution of Fc receptors on neutrophils 
has been studied by electron microscopy after soluble ferritin/ 
anti-ferritin complexes have been bound (An, 1980). Yet another 
method utilizes fluorescein-labelled antibody towards the antigen 
that has been bound: recent experiments by Tenner and Cooper
(1981) have used this technique to identify the range of cell types
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that allow Clq binding.
Perhaps the most well established technique for receptor 
detection is that of rosette formation. When suitably sensitized 
erythrocytes are brought into close contact with the appropriate 
cell, rosettes of adherent red blood cells will form around the 
receptor-positive cells. This is equally applicable to cell 
suspensions (Henson, 1977), fixed sections (e.g. of bone marrow, 
Scott,C.,1981)or macrophage monolayers(Rhodes, 1977). The propor­
tion of rosette-forming cells in a population is directly propor­
tional to the degree of sensitization of the erythrocyte. The 
steepness of the sigmoid dose-response curve has been shown to 
alter with malignant disease, and with the state of activation of 
the mononuclear phagocyte (Rhodes, 1975 and 1977).
It was thought that an alteration in the Fc receptors on 
rheumatoid granulocytes might explain the difference found between 
them and the population from normal controls in their ability 
to respond to aggregated IgG (see Figure 5.1). This was investi­
gated using a resetting technique.
Patients and Methods
The patients chosen for the study had definite rheumatoid 
arthritis with active synovitis, and all were being treated with 
NSAID. These were 5 M and 7F, mean age 59 years (range 41 - 76), 
with a mean duration of disease of 4.3 years. For comparison, 
twelve healthy volunteers were also studied, 5 M and 7 F, mean 
age 41 years (range 21 - 62).
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Rosette Assay
The IgG fraction used to sensitize calf erythrocytes was
prepared frcan a rabbit antiserum raised against calf red cell
ghosts, using affinity chromatography on Protein-A Sepharose C1-4B
(Pharmacia). The IgG was eluted with 1 M acetic acid and then
dialysed back into a 10 mM phosphate, 150 mM NaCl-containing
buffer, pH 7.4. This procedure was based on the method of Hjelm
and Hjelm, as used by Hall (Hall, 1978). The IgG was stored 
o
at -20 C in small aliquots and thawed only once before use.
Calf erythrocytes (Tissue Culture Services, Slough, Berks)
were washed out of Alsevers solution into PBS containing CaCl^
“1and MgCl^/ both at 0.01 g dl (PBSCM). After three washes they 
were resuspended to 2% and sensitized with an equal volume of 
the diluted IgG preparation detailed above. The coating was 
carried out in a 37°C water-bath for 30 minutes and the cells 
then washed thrice in PBSCM and resuspended to 1%.
Granulocytes were isolated from citrated peripheral blood
using Percoll as described in Chapter 3 (Figure 3.3.), and re-
6 —1suspended at 2 x 10 ml in PBS (without albumin) containing 
—10.16 g dl glucose. Equal volumes (200 yl) of the two cell 
suspensions were mixed in polystyrene tubes (LP3, Luckams Ltd., 
Sussex), stoppered and incubated at 4°C for 10 mins, followed 
by centrifugation at 20 g for 3 minutes, and a further incubation 
period of an hour at 4°C. All tests were set up in duplicate.
Three d œps of freshly filtered crystal violet solution
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(about 30 mg per 50 mis PBS) were added to each tube in turn 
which was then mixed on a rotating turntable (20 revs, per min • ) 
for one minute. A small amount of the resulting suspension was 
placed in a haemocytometer to scan for rosettes. A rosette was 
defined as three or more red cells surrounding, and in contact 
with, a leucocyte. At least one hundred white cells were counted 
for each test, and the percentage positive cells calculated.
Results
An initial experiment was carried out with normal subjects 
to ascertain the sensitivity of the resetting assay when a final 
red cell concentration of 1% as well as the 0.5% was used. The 
IgG was titred' in doubling dilutions from 1/200 to 1/1600, and 
unsensitized cells were always included. The results, which 
are shovn in Table 7.1, demonstrate that although the percentage 
of resetting cells was lower with the 0.5% red cells, so too was 
the level of false positives seen with the unsensitized cells.
The size of the rosettes decreased in proportion to the degree 
of the erythrocyte coating, being very large at 1/200 and 1/400 
and decreasing to 3 - 6 red cells at 1/1600. For the main study, 
a final erythrocyte concentration of 0.5% was chosen, and although 
unsensitized controls were set up in every case, the number of 
"E rosettes" was negligible.
The granulocytes from the groups of patients and controls 
were incubated with cells sensitized from 1/200 to 1/3200 








400 800 1600 None
L.E. 1.0% 97 88 ' 58 4 8
0.5% 94 89 62 4 0
P.M. 1.0% 93 84 71 28 7
0.5% 38 78 69 37 2
C.F. 1.0% 79 65 35 7 2
0.5% 77 60 30 10 0
J.W. 1.0% 91 83 69 45 1
0.5% 84 80 70 41 0
Table 7.1 The effect of altering both the final red cell 
(RC) concentration and the degree of coating 
with antibody in a standard rosette assay.
For details see text.
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7.1 and 7.2. There was no demonstrable difference between the 
two cell groups. When individuals were considered, the degree 
of rosetting was not related to the proportion of neutrophils 
in the granulocyte preparation; the mean percentage was 96 
(range 91 - 99) compared to 3% eosinophils (range 1 - 9%) . 
Occasional lymphocytes were present. Individual results could also 
not be related to the granulocyte count of the peripheral blood 
(results not given).
Discussion
This study indicated that there was no difference between 
Fc^ receptor expression on the granulocytes of rheumatoid arthritis 
patients and normal controls. It has been noted that a leuco- 
cytosis can occur during an acute exacerbation of a chronic 
inflammatory process (Baum and Ziff, 1979), more leucocytes are 
released from the bone marrow, with the possibility that some 
are not quite mature . Hurst and Nuki's observation (1981) that 
patients with rheumatoid vasculitis show a defect in monocytic 
phagocytosis of complement-coated yeast is thought to be due to 
the presence of immature monocytes in theecirculation (Hurst, 
personal communication). It has been shown (Scott C. 1979 and 1981) 
that Fc receptor expression increases during the phase between 
segmentation of the nucleus and release of the neutrophil into 
the circulation; increased emigration might therefore lead to 
an overall decrease in the ability to react with IgG-coated 
erythrocytes. Alternatively, the binding of immune complexes 
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reciprocal of sensitizing dilution
Figure 7.1
Resetting behaviour of granulocytes from rheumatoid 
arthritis patients.
Results are expressed as x ± 1 SD with the number of 










3 2 0 0 IbOO 800 400
reciprocal of sensitizing dilution
Figure 7 .2
Rosetting behaviour of granulocytes from normal subjects. 
Results are expressed as x ±  1 SD with the number of 
subjects given in brackets.
• represents the means from Figure 1 for comparison.
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the uptake of the red cells. Neither of these theories was borne 
out since no difference between the two subject groups was 
demonstrated. Rhodes has observed that Fc receptor expression 
increases with macrophage activation and is above normal in 
patients with neoplasms (Rhodes, 1975 and 1977). Non-malignant 
diseases (except tuberculosis) caused neither an increase nor a 
decrease in this expression; five rheumatoid arthritis patients, 
for instance, showed enhancement in three and depression in two 
(Rhodes, 1977). The similarity in behaviour between monocytes 
of patients and normals in the phagocytic assay described in 
diapter 5 reflects this finding.
Hall and Winrow have made a study of the IgG receptors on 
lymphocytes from a group of patients equivalent, but not identical, 
to those used in the assay described in this chapter. EA rosette 
formation by mononuclear cells was increased in RA patients 
over normals, being 21% compared to 13% for 1/800 coating, P < 0.005 
When the red cells were coated with a limited digest fragment 
of IgG, termed Facb, rosettes were again formed more often in 
RA patients than in controls, and this was true whether or not the 
monocytes were removed by carbonyl iron treatment (Hall, Winrow 
and Bacon, 1980). The significance of these findings is as yet 
unestablished, but the difference between lymphocytic and neutro­
philic rosette formation possibly reflects the very different 
roles of the cells in the immune response.
Since there appeared to be no distinction between the 
Fc^ receptors on granulocytes, it was considered expedient to
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study other properties of these cells that might have a bearing 
on the phagocytic response.
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CHAPTER EIGHT FURTHER STUDIES ON PHAGOCYTES, II. BIOCHEMICAL
EVENTS
Introduction
. Phagocytic leucocytes are metabolically stimulated when they 
bind micro-organisms with the resultant production of microbicidal 
molecules such as superoxide (O^'), hydroxyl radicals (’OH) and 
hydrogen peroxide (̂ 2̂^2  ̂ together with a transient light emission 
(Klebanoff, 1975; Rosen and Klebanoff, 1979; Easmon et ai., 1980). 
The same activation occurs whether the cell is exposed to chemo­
tactic peptides (Kitagawa, Takaku and Sajamoto, 1980b; McPhail, 
Henson and Johnson, 1981), immunoglobulin aggregates (Henson and 
Oades, 1975; Treadway et ai., 1979), surface-bound immunoglobulin 
(Kiyotaki et ai., 1978) or zymosan (Doll, Wilson and Salvaggio,
1980; Easmon et ai., 1980; van de Stadt, van de Voorde-Vissers 
and Feltkarap-Vroom, 1980).
The majority of studies have been carried out on PMN leuco­
cytes , for instance by Henson and Oades (1975); Rosen and 
Klebanoff (1979); Roos et ai., (1980) and McPhail, Henson and 
Johnson, (1981). Evidence supporting the presence of an equivalent 
system in mononuclear phagocytes has been provided by, for example, 
Kitagawa, Takaku and Sakamoto, (1980a and 1980b);Wilson, Tsai 
and Remington, (1980); Nakagawara, Nathan and Cohn, (1981) and 
Williams and Cole, (1981). This latter cell type, however appears 
to produce less of these highly reactive products than does the 
the granulocyte (Reiss and Roos, 1978; Johnson RB, Lehmeyer 
and Guthrie, 1976).
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The interaction of the many metabolites generated during this 
process has already been outlined in the Introduction to this 
thesis (Figure 1.2, Chapter 1). Assays for measuring most of them 
are available and thus provide a means of assessing cell activation 
and, indirectly, phagocytic activity. The overall increase in 
hexose monophosphate shunt activity (with an increased oxygen 
consumption) has been known and measured for many years (Malawista 
and Bodel, 1967; Henson and Oades, 1975; Treadway et al., 1979; 
van de Stadt, van de Voorde-Vissers and Feltkamp-Vroom, ].980) . 
Measurement of the metabolites is dependent upon leakage of the 
active molecules or related enzymes into the extracellular milieu 
(Henson, Johnson and Spiegelberg, 1972; Root et al., 1975;
Babior et al., 1981) and the efficiency of detection is influenced 
by this.
Small quantities of ^2^2 solution can be detected by 
the horseradish peroxidase - mediated oxidation of scopoletin which 
fluoresces only in its reduced form (Root et al., 1975). Singlet 
oxygen oxidises methionine (Tsan and Chen, 1980). Superoxide 
can function as a reductant, reducing ferricytochrome C (Rosen and 
Klebanoff, 1976; MacGregor, Macarak and Kefalides, 1978; Babior 
et al., 1981), or nitroblue tétrazolium (NBT) (Wenger and Bole, 
1973; Lambert, Roberts and Wright, 1978), or as an oxidant 
towards epinephrine'(Rosen and Klebanoff, 1976). Lucigenin- 
dependent chemiluminescence appears also to be mediated by O , 
while the luminol-dependent emission seems to be a result of 
the activation of more than one molecular species (Easmon et al., 
1980; Williams and Cole, 1981b).
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The oxidation of serum thiol groups by phagocytosing polymorphs 
has recently been delineated in this laboratory by Hall and Blake 
(1981); it too is multifactorial, being dependent upon HgOg,
‘oh radicals and possibly singlet oxygen (^O^)- Serum sulphydryl 
levels are depressed in patients with active RA (Lorber et al.,
1964; Haataja, 1975) and rise with good patient response to 
anti-rheumatic drug therapy (Hall, Blake and Bacon, 1981). Hall 
and Blake (1981) suggest that this change could be related to 
free radical scavenging associated with phagocytic activity 
towards immune complexes which are decreased after chemotherapy.
The independence of the metabolic stimulation from exocytosis 
(Goldstein et al., 1975) facilitates investigation of the effects 
of small macronolecules such as rheumatoid factor and soluble 
aggregates. It also allows direct comparison of cellular activation 
and measurable degranulation; in the light of the finding that 
rheumatoid peripheral blood granulocytes are less able to 
degranulate than their normal counterparts (see Chapter 5), it 
was considered of value to correlate this result with that of 
free radical release.
There appears to have been very little work carried out on 
the oxygen species released by rheumatoid phagocytes. Van de Stadt 
and co-workers could find no difference in oxygen uptake as compared 
to control granulocytes (1980), and the reduction of NBT appears 
to be normal (Wenger and Bole, 1973; Lambert,- Roberts and Wright, 
1978). Free-radical mediated peroxidation of serum and synovial 
fluid lipids has been studied with reference to RA and other
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arthritic conditions. Synovial fluids from inflammatory diseases 
(mostly ankylosing spondilitis and RA) had a higher level than 
non-inflammatory arthritides (most osteoarthritis); and the serum 
peroxidation of RA patients was raised above normals (Lunec at ai.,
1981). This is an overall response, and the authors noted that 
"the specificity of the changes in RA therefore needs to be 
defined".
In consideration of the changes in serum thiol levels in RA, 
it was decided to use their oxidation as a measure of phagocytic 
activation. Since this assay appears to be independent of super­
oxide, it was thought expedient to assess this moiety separately 
using the ferricytochrome C assay. The major features of this 
section are, therefore, as follows :
One: the comparison of granulocytes from normals and RA patients
for superoxide (ferricytochrome C), other radicals (Thiols) 
and g-glucuronidase release.
Two: the assessment of superoxide and g-glucuronidase release
from both monocytes and granulocytes exposed to soluble 
aggregate, particulate aggregate (HAGG), rheumatoid 
factor and synovial fluid complexes, either singly or in 
combination.
Related aspects are presented and discussed.
Methods and Materials
1. Patient and control groups.
Thiol oxidation experiments: Ten patients were studied, 4 M
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and 6 F, age range 40 - 77 (mean age 55 years). All had synovitis, 
and one also had nodules and fibrosing alveolitis. Eight were 
seropositive and two seronegative. The mean duration of disease 
was 13.6 years, range 9 months to 35 years. No patient of this 
or following groups was being treated with second-line, anti­
rheumatic therapy.
Nine controls volunteered, 2 M and 7 F, age range 20 - 59 (mean 
age 40 years).
Ferricytochrome C experiments; First group:
There were ten patients, 1 M and 9 F, age range 45 - 72 (mean 
age 58 years). All had synovitis, one also had severe erosions 
(ACA of 1/4, latex 1/4096), and one fibrosing alveolitis. Nine 
were seropositive, one seronegative. The mean duration of disease 
was 5.4 years, range 5 months to 15 years. Twelve controls were 
used for comparison: there were 3 M and 9 F, age range 2 0 - 5 9
(mean 37 years).
Second group: (buffer experiments)
Nine patients, 3 M and 6 F, had an age range of 35 - 74 (mean age 
55 years). Seven were seropositive, one seronegative and one unknown. 
The mean disease duration was 10.4 years, with a range of 9 months 
to 35 years.
The controls consisted of 1 M and 6 F (one used twice), age range 
25 - 60 , mean age 43 years.
Third group: (Modulation experiments)
This group was made up entirely of normal controls and was composed 
of 6 M and 4 females.
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2. Methods
Granulocyte and mononuclear cell suspensions were prepared 
as described previously (Chapter 3, see Figure 3.3). The protein- 
aceous reagents, that is, rheumatoid factor (MxRF), soluble 
aggregate, HAGG and synovial fluid complexes were as detailed 
in Sections 2.3 and 2.5 as were the conditions for phagocytosis 
of HAGG leading to release of g-glucuronidase. In some of the 
experiments the granulocytes were suspended in buffered Earles 
Balanced Salt Solution without phenol red (EBSS), and the reagents 
in M 199 plus 10% FCS, so that the concentration of FCS was 
effectively reduced to 4 - 5%. The implications of this are 
presented in the Results section.
All tests were carried out in duplicate.
Oxidation of thiols by activated granulocytes:
The incubation conditions for this assay were, cells at
6 ~1 -1 2.5 X  10 ml in EBSS, HAGG at 200 yg ml and as a source of
thiols (SH) normal human serum (50 yl ) to a total volume of 760 yl.
After an incubation time of 2 to 30 minutes in a 37°C water
-1bath, 40 yl of catalase at 3 mg ml (Thymol-free, from bovine 
liver. Sigma) was added to decrease the chance of further 
oxidation occurring (Hall and Blake, 1981). The reaction tubes 
were cooled in crushed ice before being centrifuged at 1000 g for 
5 minutes at 4°C in a temperature-controlled centrifuge. The SH 
assays were carried out as described by Hall and colleagues (Hall, 
Blake and Bacon, 1981), adapted by them for cell supernatants 
(Hall and Blake, 1981). Seven hundred microlitres of the supernatant 
was added to 100 yl of 0.1 M phosphate buffer pH 7.4, followed
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by 200 yl of DTNB (5,5' dithiobis (2-nitrobenzoic acid); Sigma) at 
■“X0.8 mg ml in 0.1 M phosphate buffer pH 7.4. After five minutes
at 37°C, the absorbance of the reaction mixture was determined
at 440 nm in a Cecil spectrophotometer. This was converted to
-1serum SH levels (as ymol 1 ) using a factor derived from a
calibration curve (Hall, Blake and Bacon, 1981), taking into 
account the 7 in 8 dilution of the cell supernatant., SH levels 
from serum samples were determined likewise (50 yl serum, 750 yl 
buffer and 200 yl DTNB).
Superoxide generation:
6 -1Granulocytes were studied at a concentration of 5 x 10 ml
6 “1and mononuclear preparations with the monocytes at 2 or 2.5 x 10 ml 
(average 27% monocytes), The cells were incubated with various 
stimuli in the presence of 150 yM ferricytochrome C (type III, 
from horse heart. Sigma) as suggested by Roos and colleagues 
(1977), in a final volume of 250 yl, the diluent being EBSS.
Each test was set up in quadruplicate; two for a direct determin­
ation and two containing, in addition, superoxide disroutase 
-1(SOD) at 10 yg ml in order to determine the level of non-specific 
cytochrome C reduction (Goldstein et al., 1975). After incubation 
in a 37°C water bath, usually for 30 minutes (see Results),. the 
reaction mixtures were spun at 1000 x g for lO minutes at 4°C 
in a temperature-cohtrolled centrifuge. One hundred microlitres 
of each supernatant was then removed into 1.1 mis of 0.1 M 
phosphate buffer pH 7.4 (Goldstein et al., 1975) and kept for 
up to two hours at 4°C. The absorbance at 550 nm was then 
measured in a Cecil spectrophotometer against a blank incubated 
without cells. Separate tests, also without cells, were treated
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-3with potassium ferricyanide (final concentration 1.5 x 10 M)
-3and with ferrous sulphate (Michelson, 1977) at 1,5 x 10 M, 
to determine the amount of cytochrome C that was reduced and 
the total amount present (reduced/oxidized respectively). The 
readings were converted to concentrations using an extinction 
coefficient of 21.1 mM cm at 550 nm (van Gelder and Slater, 
1962; Goldstein et ai., 1975), and expressed as nanomoles of 
ferricytochrome C reduced per 10^ phagocytes. The reduction in 
the presence of SOD was subtracted fran the value in its absence 
to give the reduction specific to superoxide.
Results
3. Phagocytic oxidation of sulphydryl groups:
Preliminary experiments were carried out to standardize the 
thiol oxidation by granulocytes. Resting cells had no overall 
effect on the level of serum sulphydryls, whereas actively phago­
cytosing cells oxidized the thiol groups (Table 8.1). Titration
of the aggregated IgG suggested that the response was maximal 
"1at 2(X) yg ml (data not shown), so this concentration was used 
throughout. Time course experiments were carried out in a group 
of ten patients and nine controls, the data from which are 
presented in Figure 8.1. There was a consistent trend towards 
increased oxidation'of the thiol groups by patients' PMN.
However there was a high variability, especially amongst the 
control subjects, which diminished the statistical significance 
of this apparently increased oxidative activity. Only at 6 minutes was 
there a definite difference (0.05 > P > 0.02), while at 10 and 
30 minutes significance was not established (0.1 > P > 0.05).
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Table 8.1. The effect of granulocytes on serum thiol groups.
Concentration of SH in serum 
(ymol I
Subject....................EB BC EL
serum only 604 554 670
serum + cells 541 583 710
serum + cells + HAGG 344 345 480
Table 8.2. The release of g-glucuronidase by granulocytes.
% release above background 
(HAGG at 200 yg ml“ )̂
X 1 SD
Patients, n = 8 13.3 3.94
Controls, n = 7 12.8 3.06
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Separate tests were also set up for 8-glucuronidase release in 
eight of the patients and seven of the controls, and the results 
are summarized in Table 8.2. Surprisingly, there was no difference 
between the two groups. The correlation coefficient for 8-glucu­
ronidase release versus thiol oxidation was only 0.16 and not 
significant. Lactic dehydrogenase release was assessed for both 
thiol-oxidation and g-glucuronidase tests in nine of the subjects. 
The release was higher in the former (7.8 ± 5.4%) than in the 
latter (1.5%), after adjustment had been made for the presence 
of the fresh human serum.
4. Superoxide release by phagocytes :
Granulocytes from control volunteers were exposed to between 
—150 and 500 yg ml of HAGG in the presence of ferricytochrome C.
-1Maximal reduction took place between 200 and 400 yg ml  ̂ and 
—1300 yg ml was chosen for this study. A time course experiment 
was performed: as shown in Figure 8.2 (two normals), the major
part of the release of superoxide occurred before 15 minutes, with 
a smaller change thereafter. A thirty minute incubation period 
was chosen for routine use.
A study was made of twelve controls and ten patients with 
active RA, and the results are shown in Table 8.3. There were no 
demonstrable differences between the two groups for either super­
oxide or g-glucuronidase release, nor was there a significant 
correlation between the two variables (r - O.18). The LDH release 
was higher than expected, being 11.4 ± 4.8% (n = 15). It was not 
obviously related to either background or stimulated superoxide
Legend to Figure 8.1.
The oxidation of thiol groups in serum by phagocytosing granulocytes,
. _ SH oxidized by cells responding to HAGG% SH groups oxidized =  rr:-- r-rf-----TT----- -̂---------------SH oxidized by resting cells
-1HAGG used at 200 yg ml
Results plotted as mean plus or minus one standard deviation 
^  patient group 
O  control group 
Statistical data:
time (minutes ) P value
2, 4, 8 not significant
6 0.05 > P > 0.02
10,30 0.1 > P > 0.05
Legend to Figure 8.2.
The reduction of ferricytochrome C by phagocytosing
granulocytes.
Abscissa: Time of incubation
Ordinate: n moles of ferricytochrome C reduced by 10^ PMN 
(reduction in the absence of SOD minus that in 
its presence i.e. superoxide specific)
• subject S.B., with HAGG
o subject S.B., without HAGG
X subject N.H., with HAGG
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Figure 8.2
See legend opposite Figure 1
Table 8.3. Superoxide and 3-glucuronidase release
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by granulocytes.
n moles ferricytochrome C Patients Controls
6reduced per 10 PMN X  ± 1 SD X  ± 1 SD
(superoxide specific): n = 10 n = 12
without HAGG 1.09 ± 0.71 0.57 ± 0.87
with HAGG (300 yg ml ) 4.33 ± 1.24 4.89 ± 2.29
change with HAGG 3.24 ± 1.39 4.32 ± 2.52
(background subtracted at 
source)
% 3-glucuronidase released 21.56 ± 5.29 21.80 ± 9.21
(background subtracted at
source) (n = 8) (n = 8)
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release by tlie cells. The effect of an identical concentration 
of ferricytochrome C on the activity of purified LDH (type XII, 
from human erythrocytes) was assessed using the standard assay 
system, but no alteration of enzyme activity could be demonstrated.
5. Beta-glucuronidase release:
The discrepancy between tlie g-glucuronidase release demonstrated 
in these experiments and those described in an earlier chapter 
(Chapter 5, figure 5.1) necessitated a careful assessment of any 
changes that had been made in the procedure. The only difference 
was that instead of being suspended in M 199 plus 10% FCS, the 
granulocytes were in EBSS. The stimuli were, as before, diluted 
in the medium with serum, so that the final concentration was 
40 - 50% M 199 plus 4 - 5 %  FCS. The effect of these changes 
was evaluated,using five patients and four controls, and Figure 8.3 
depicts the results. The media had little effect except in the 
case of two patients whose cells responded much better in the 
EBSS/M 199 than in the M 199 alone.
It was noted that all controls were more active than patients, 
as had been found previously. In consequence four each of controls 
and patients had their neutrophils assessed for both 3-glucuronidase 
and superoxide, and the results compared (Figure 8.4). There was 
again no correlation between the two indicators (r = 0.26), but 
patients showed a tendency towards a lower enzyme release. For 
statistical analysis, the data from this and the previous experi­
ment (with media) were pooled; patients showed a lower release 
of the 3-glucuronidase than did the controls, 21.4 ± 4.2% compared
Legend to Figure 8.3.
The effect of different media on the release of 3-glucuronidase 
from granulocytes.
5 M - M 199 with 5% FCS
5 EM - M 199 with 10% FCS v/v EBSS (final FCS' of 4-5%)
10 M - M 199 with 10% FCS
_ 1
Stimulus 300 yg ml HAGG
Legend to Figure 8.4.
Degranulation and superoxide release in phagocytosing 
granulocytes.
Ordinate: % release, of 3-glucuronidase (minus background)
Abscissa: n moles of ferricytochrome C reduced by 10^ PMN
X RA patients 
• Controls























A comparison of enzyme and superoxide release by 
granulocytes.
See legend opposite Figure 3.
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to 31.2 ± 5.8%/ a ratio of 1 to 1.46 (0.01 > P > O.OOl). This 
agrees closely with the data presented in Figure 5.1/ where the 
ratio is 1 to 1.44. The difference in actual levels of release 
probably relates to the batch of aggregate used.
6. Inactivation of beta-glucuronidase;
Throughout the experiments in this thesis that involved 
measuring the acid hydrolases/ it was noted that an overall 
decrease of enzyme activity occurred in stimulated phagocytes.
That is;
amount released + amount remaining (lysate) ^----- —  ----------:------— ------ ------- ■4--—  = Less than Unity,amount of enzyme in resting cell (lysate)
Because this may be related to effects of reactive oxygen species
(Voetraan et al., 1981)/ the degree of change was calculated for
the series of experiments summarized in Figures 5.1 and 5.2. The
above equation was used with conversion to percentage activity
by multiplying by one hundred. Similar results were obtained
for each concentration of HAGG and representative data are
portrayed in Figures 8.5 and 8.6. Both MNC and PMN showed the
ability to inactivate 3— glucuronidase though MNC were less
able to do so than granulocytes. A difference between normals
and RA patients was only demonstrated in one case/ that of PMN
-1responding to 50 yg ml HAGG; rheumatoid phagocytes shoved less 
inactivation of enzyme with a P value of < 0.05.
Five patients (not included in the above calculations) 
lacked the ability in one of the two cell types to induce this
Legend to Figures 8.5 and 8.6.
The inactivation of 3-glucuronidase by phagocytes,
Ficure 5 Pt4N >
Ficure 6 MNC f RA Patients A  Controls Q






enzyme releasedfenzyme remaining in lysate x lOO 
I enzyme in resting cell (lysate)
Statistical importance of the inactivation
50 200
P<< 0.001
-1500 yg ml HAGG
P< 0.001
P <  0.001 0.01 > P > 0.001 0.05 > P > 0.02
P < 0.001 P<  0.001 O. 01 > P > 0.001
P calculated from t = X = 100
X  -  %  a c t i v i t y
symbol_____ patient history





Felty's syndrome. NSAID prior to Gold therapy.
Cyclic leucopenia. R^ of aspirin, amoxycillin 
and prednisolone 5 mg
Definite RA with active synovitis. NSAID.
Definite RA, psoriasis and active synovitis. 
Treated with NSAID.
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05 >  P > . 0 2P value NS NS
Number 17,17 19,19 17,17






















See legend opposite Figure 5.
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change. None responded abnormally with both cell preparations.
All showed adequate 3-glucuronidase release.
Inactivation did not correlate with either thiols oxidized
(r 0.09, n = 15), cytochrome C reduced (r = 0.25, n = 16) or
3-glucuronidase released (r = -0.17, n = 19 for patients, r = -0.29,
n - 18 for controls) when granulocytes were involved. When the
latter was calculated for MNC, the controls again showed a lack
of dependency (r = -0.28, n = 17), while the patients cells
appeared to demonstrate a positive relationship between inactivation
and enzyme release (r = -0.55, n = 17; 0.05 > P > 0.02). The
coefficient r is negative because nil inactivation leaves 100%
of the enzyme remaining, and total inactivation would stop all
enzyme activity. The group of 4 patients and 4 controls also
showed no correlation between the variables. Most of these
calculations were carried out on data from experiments with 
-1200 yg ml of HAGG; reduction of cytochrome C with PMN was in
—2̂response to 300 yg ml HAGG.
7. Activation of phagocytes by small macro-molecules. 
Ferricytochrome C reduction:
It has been determined that rheumatoid factor preparations, 
soluble aggregates and immune complexes from synovial fluid 
cause little, if âny, degranulation by phagocytes (see Figure 
4.4 and Chapter 6.6). Their ability to stimulate the cell, 
leading to superoxide release, was investigated. The rheumatoid 
factor preparation was IgG/igM, designated as MxRF (Chapter 6); 
it reacted with mononuclear cells in 4 out of 6 cases, and with
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granulocytes in 6/6 cases, although at a lower level. Soluble 
aggregates were as active in stimulating the cells as was the 
particulate HAGG, and the synovial fluid IgG (SF IgG) aroused 
a similar response. Subjects 1 and 3 demonstrated high release 
from resting neutrophils that was in excess of the level 
x+1 SD (0.64 + 0.60) calculated fron previous experiments, and 
this increase was reflected in almost all responses. Subsequent 
to the investigations on subject 3, the'sterile' stock of EBSS 
was found to be contaminated and was discarded. It is probable 
that these abnormal results were a consequence of the presence 
of endotoxins, to which neutrophils were more sensitive than the 
monocytes. The background superoxide release was subtracted 
from that of the other test values for PMN, subjects 1 and 3. 
Although subject six’ PMN generated superoxide in the resting 
state this did not raise stimulated values, so could not with 
validity be subtracted from them.
The results, as shown in Figures 8.7 and 8.8, indicated 
that it was difficult to be quantitative about the reduction 
of cytochrome C. The addition of twc stimuli concurrently 
produced no consistent increase or decrease in the release 
of superoxide (Table 8.4) which reinforced this impression..
An attempt was'made to ascertain whether or not a plasma 
containing immune complexes could stimulate the cells' oxidative 
metabolism. The plasma D.C. (described previously. Chapter 4; 
Materials and Methods) was compared to two normal sera that were
ACA and RF latex negative with normal CH , and all were utilized— 50
at a final concentration of 50% in t h e  assay, i n  place of a s t i m u l u s .
Legend to Figures 8.7 and 8.8.
Tlie ferricytochrome C reducing ability of phagocytes in
response to various stimuli.
6 -1Figure 7: PMN at 5 x 10 ml
6 -1Figure 8: MNC, with monocytes at 2.5 x 10 ml (controls 1-3)
S —12 X 10 ml (controls 4-6) 
Ordinate: n moles reduced per 10^ cells (superoxide specific)
(30 minute incubation)
Absicissae: stimuli as follows:
None
-1HAGG at 200 pg ml 
500
-1MxRF at 60 yg ml
“1Sol Agg 500 yg ml 
-1SF IgG 500 yg ml
The numbers within the bars refer to the 6 control subjects 
used. For PMN, numbers 1 and 3 are presented with background 
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See legend opposite Figure 7.
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Table 8.4. The effect of concurrently administered stimuli on 
ferricytochrome C reduction.
, , - n moles reduced in the presence of two stimuliValues equal ---- ;---------- ---- rr— ^----------    :--- — ---:--n moles reduced in the presence of a single stimulus
Numbers in parentheses refer to values with background subtracted.
-1Stimuli as in Figures 7 and 8 (HAGG at 200 yg ml )
SA = soluble aggregate 
H = HAGG
MNC PMN
Subj ect RF + HRF
RF + H 
H
SA + H 
SA
SA + H 
H
SA + H 
SA
SA + H 
H
1 a 1.89 1.08 1.68 1.37
(1.61)
a
2 1.91 3.03 0.64 1.01 a 1.34




4 0. 30 0.20 0.0 0.0 1.68 1.20
5 a 0.61 0.91 1.05 1.75 1.65




In 2 of the 3 granulocytes preparations, plasma D.C. induced more 
reduction of cytochrome C than did normal sera, while in the 
third the position was reversed. In addition all sera manifested 
an apparently SOD-resistant ability to reduce the cytochrome C,
No firm conclusions could therefore be made.
Related experiments;
In conjunction with the investigation into the effect of 
rheumatoid factor and other compounds on production of superoxide, 
they were also judged for 3“glucuronidase release v;ith special 
reference to their modulation of the response to HAGG. It had 
been discovered that the rheumatoid factor containing both IgG 
and IgM (MxRF) had no effect on the response of PMN to HAGG, 
but decreased that of monocytes (Figure 6.1). It was decided to 
ascertain the properties of soluble IgG aggregates in this 
respect, and to compare them with the MxRF. Preliminary experi­
ments with four controls in which soluble aggregate was titred
-1against HAGG suggested that concentrations of 500 and 200 yg ml 
respectively, gave readily detectable responses with both mono­
cytes and neutrophils , (results not shown). MXRF was used 
—1at 60 yg ml as in previous work. Cell concentrations were 
as in Figures 8.7 and 8,8.
The data presetted in Figure 8.9 show that soluble aggregates 
do not influence the degranulation of neutrophils (effect,
X  = 1.1 ± 0.2). When mononuclear cells were tested, however,
4 out of 6 were inhibited by the presence of soluble aggregates, 











The interaction of granulocytes with soluble and 
insoluble -aggregates of IgG: release of ^-gluc­
uronidase (background subtracted).
stimuli
—  1 —  1500 jug ml" Sol Agg plus 200 Jig ml" HAGG





The numbers within the bars refer to the 6 control subjects 
used.










500 _^g ml Sol Agg plus 200 _pg ml” ' HAG!
The release of ^-glucuronidase by mononuclear cells (back­
ground subtracted) in response to rheumatoid factor (KxRF), 







ratio of release Sol Agg 4-HAGG
-16 0  jxg ml MxRH 
- 1






The numbers below the bars refer to the 6 control subjects 
used.
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close correlation between the inhibitory efficiency of the two 
types of protein, and this is illustrated in Figure 8.11, The 
low P value strongly suggests that a common process was taking 
place.
The mixed rheumatoid factor did not induce inactivation of 
intracellular 6-glucuronidase in monocytes (activity was 96 ± 15%, 
n = 4) or in PMN (100%, n = 2), and neither did soluble aggregates 
(103 ± 14%, n = 9; 109 ± 22%, n = 8, respectively) or
SF IgG ( l o o  ± 10%, n = 6 ;  106 ± 23%, n = 6). Similar calculations
for the pure IgM RF used in previous experiments also indicated 
that this was the case (102 ± 8% for monocytes, 96 ± 10% for 
PMN), although the monocytes had not in this instance inactivated 
tlie enzyme in response to HAGG (97 ± 11%). The percentage 
activity left in the neutrophils exposed to HAGG was 69 ± 11%, 




The relationship between the inhibition of response 
to HAGG by rheumatoid factor (MxRP) and soluble 





Sol Agg 4-HAGG 
HAGG alone
The observed correlation is significant, r = 0 . 9 4  
and .01 >  P >  .001
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Discussion
The experiments presented in this chapter revealed three 
broad areas of interest. The two features of possibly lesser imp­
ortance, that is the effect of serum on phagocytosis and the 
measurement of lactic dehydrogenase,are discussed prior to con­
sidering the release of oxidative molecular species.
8. The importance of the medium
The influence of serum on the phagocytosis of HAGG has been 
discussed, after the finding that the presence of heat-inactivated 
foetal calf serum increased the release of 3“glucuronidase by 
PMN (Chapter 6; Table 6.2) from normals. The effective decrease 
of serum concentration to 5% made in these experiments, did not 
Cause an equal decrease in release from controls and patients, 
so that the differential response found previously (Figure 5.1) 
was abolished. Neither was the effect unipolar within the groups 
(Figure 8.3). This unexplained reliance upon the presence of HI, 
or decomplemented, serum needs to be investigated. Had the tests 
which showed no difference between the two groups of patients and 
controls been performed in the presence of 10% FCS, a difference 
in response may well have been demonstrated. In fact, subsequent 
experiments did demonstrate responses which were in close agree­
ment with the data presented in Figure 5.1 (see Results 8.3).
9. The measurement of lactic dehydrogenase.
The apparently high LDH activity found in the presence of 
ferricytochrome C is likely to be an experimental artifact, 




NADH + H + pyruvate ---------- ^ NAD + lactate
absorbs at 340 nm
Ferricytochrome C can also be reduced by this compound:
-f- "j-NADH + 2 ferricytochrome C ---- > NAD + 2 ferrocytochrome C + H
(van Gelder and Slater, 1962)
The finding that an enhancement of NADH disappearance did not 
occur when only purified LDH was used strongly suggests that this 
second reaction was catalysed by something released by the cells 
into the supernatant.
Other experimenters have measured LDH activity in the absence 
of cytochrome C (Goldstein et al., 1975; McPhail, Henson and 
Johnston, 1981), or have carried out a dye-exclusion test for 
viability after the assay itself (Kitagawa, Takaku and Sakamoto,
1980). This latter method seems to be the most promising in 
assessing the actual effect of ferricytochrome C on cell viability
10., Oxygen-dependent products
Oxidative molecular species released from stimulated phago­
cytes were measured by their ability to oxidize serum thiols and 
to reduce ferricytochrome C. Serum sulphydryl levels are 
depressed in RA patients (Lorber et al., 1964; Haataja, 1975), 
and since they can be oxidized by phagocytosing PMN (Hall and 
Blake, 1981), it was of interest to ascertain if rheumatoid 
granulocytes release relatively more oxidizing molecules than do 
those from controls. There were indications that rheumatoid
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patients' cells did indeed oxidize serum thiol groups more readily 
til an did controls' cells, but no firm conclusions could be drawn 
because the SH oxidation was found to be very variable (See 
Figure 8,1). Thus it seems likely that the decrease of reduced 
serum thiols to about 60% of normal levels (Lorber et al., 1964) 
is owing, at least in part, to two factors. These are the apparent 
tendency for patients' cells to more readily oxidize thiols, and 
to the .increased frequency with which the granulocytes are likely 
to be stimulated to release active oxygen species after binding 
complexes and the like deposited at vessel walls. In support of 
this, it has been reported by Lorber et al. (1964) that the most 
severely depressed serum sulphydryls are to be found in connective 
tissue diseases associated with vasculitis (e.g. rheumatoid 
arthritis complicated by vasculitis).
This assay system might prove useful towards deciding at 
which level the second-line drug D-penicillamine acts to effect 
a return to normal serum thiol levels (Hall, Blake and Bacon,
1981). Anti-inflammatory drugs have been shown to inhibit 
superoxide production ( Oyanagui, 1978),
and if they have similar action on the cells’ ability to oxidize 
thiols this should be demonstrable using the described technique.
The kinetics of release of superoxide found in the present 
studies (Figure 8.2) (as measured by ferricytochrome C reduction) 
were very close to those demonstrated by both Simchowitz and 
Spilberg (1979) and Goldstein and colleagues (1975). The latter 
used aggregated IgG as one of the stimuli. Goldstein showed this
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activity to be independent of 3-glucuronidase release and this 
was also found to be true for the present experiments (Figure 8.4) 
This is possibly because the two are temporally distinct, the 
change in oxygen consumption occurs at particle uptake and closure 
of vacuole (about 20 seconds) while degranulation occurs at about 
400 - 700 secs (Segal, Dorling and Coade, 1980). Degranulation 
need not follow the first event at all (Goldstein et al., 1975; 
Reiss and Roos, 1978). In the light of this lack of correlation 
it was not unexpected to find that superoxide production was no 
different in rheumatoid and normal granulocytes (Table 8.3). The 
slightly increased background release of rheumatoid neutrophils 
was probably not important given the variability of all the 
results (see Table 8.3), and although it diminished the 
apparent release with HAGG, there was no significant difference 
between the groups.
The inactivation of acid hydrolases that occurred during 
phagocytosis was noticed early on in the present project. It 
is not a phenomenon commonly described, although at least one 
group of scientists have published their findings in relation 
to chronic granulomatous diseases (CGD) (Voetman et al., 1981). 
Phagocytes from these patients did not inactivate their own 
enzymes, which strcngly suggests that reactive oxygen products 
are the active agents. This is reinforced by the fact that 
inactivation did not occur under anaerobic conditions. The in­
activation appeared to be caused by the combined action of 
myeloperoxidase and hydrogen peroxide (Voetman et al., 1981). 
Almost all the rheumatoid patients' cells behaved comparably
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with normals, only showing , slightly less inactivation by PMN at 
one concentration, the significance of which was not established. 
Five of the patients behaved abnormally: two (both women with
leucopenia) had granulocytes that failed to block their enzymes. 
One of the patients was definitely diagnosed as suffering from 
Felty's syndrome. Although their release of 6-glucuronidase, was 
apparently normal , and not increased as in CGD cells (Voetman 
et al,, 1981) it was at the upper limit of rheumatoid activity 
for both patients (17.3 and 18.7% c.f. 13.9 ± 4.0%, see Figure 
5.1). It is therefore difficult to determine the effect this 
property is having on overall release. It would have been inter­
esting to study this phenomenon in more patients suffering from 
Felty's syndrome, but many were already being treated with 
second-line therapy. One of the drugs within this group, 
notably D-penicillaraine, has been shown to prevent superoxide- 
mediated changes in collagen and in hyaluronic acid (Greenwald, 
1981) and to reduce the thiol groups in serum and glutathione 
in erythrocytes (Hall, Blake and Bacon, 1981; Munthe, Kass 
and Jellum, 1981). Munthe has shown this dncrease in reduced 
glutathione to also occur in response to some other anti-rheumatic 
compounds. It was therefore considered unwise to include such 
patients in the study. There were no specific features of 
rheumatoid disease in the three patients whose monocytes 
failed to inactivate their 6-glucuronidase, for all had active 
synovitis as part of definite RA. Release of the enzyme was 
spread through the range of rheumatoids (16.6, 11.3 and 10.1 c.f. 
12.9 ± 4.9%).
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The apparent increase in activity of the acid hydrolase may 
point to the activation of latent enzyme within the stimulated 
cells. This would in turn mean that in the normal cell a greater 
inactivation is occurring than is directly measurable. This has 
not been reported in the CGD cells for 3-glucuronidase, although 
a slight transient increase has been noted to occur with 
lysozyme (Voetman et al,, 1981).
It had been tliought possible that the lower release of 
3-glucuronidase by rheumatoid granulocytes (Figure 5.1) might be 
a direct result of an increased inactivation, but this was not 
validated by the results obtained.
In the same way that active oxygen species are generated 
without a need for degranulation, phorbol myristate acetate, 
which induces almost no 3-glucuronidase release, has been reported 
to promote inactivation of lysosomal enzymes (Voetman et al., 
1981). However, the soluble aggregates and mixed rheumatoid 
factor preparations used in the present studies failed to induce 
this alteration although both were capable of stimulating super - 
oxide production. Elucidation of the exact mechanism whereby 
a cell induces inactivity in its own enzymes may help to explain 
these differences.
Monocytes have been reported to release less superoxide 
in response to zymosan than do neutrophils, primarily because 
seventy percent of the increased oxygen uptake in monocytes is 
utilized in mitochondrial respiration (Reiss and Roos, 1978). 
However the response to sane formyl peptides, concanavalin A
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and wheat germ agglutinin appears similar or higher in monocytes 
(Kitagawa, Takaku and Sakamoto, 1980). When paired granulocytes 
and mononuclear cells were used in this study (Figures 8.7 and 
8.8) neither cell type showed a consistent increment over the 
other. However the inactivation of B-glucuronidase by monocytes 
(Figure 8.6) was less effective than that by granulocytes (Figure 
8.5), which does suggest that the latter release more oxygen 
metabolites when stimulated by aggregated IgG .
When monocytes are cultured in vitro over four weeks they
take on the morphological characteristics of macrophages, and
by ten days retain less than six percent of their original capacity 
to secrete HgO^ and O^’ on challenge with opsonized zymosan or 
phorbol myristate acetate (Nakagaward, Nathan and Cohn, 1981) . It 
is interesting that human alveolar macrophages are unable to 
produce lumino1-dependent chemiluminescence, which has a similar 
dependency (Williams and Cole, 1981). The driving force for 
the monocytes to differentiate in vivo (and in vitro) is a 
property that the neutrophil lacks so that, teleologically 
speaking, the short-lived cell must act quickly with its bacteri­
cidal mechanism.
It was discovered in the work earlier in this thesis (Chapter
6) that granulocytes and monocytes behaved differently in the
presence of rheumatoid factors. Because the inhibition of response 
to HAGG was only mediated by the MxRF, it was useful to ascertain 
whether this preparation contained self-associated complexes that 
were able to stimulate the phagocytes into their oxygen burst. This
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was found to be the case. The MxRF promoted superoxide release
in both monocytic and neutrophilic cells (Figures 8.7 and 8.8). The
latter type appeared less easily stimulated. It was not possible
to investigate the effect of the pure IgM RF because of lack of
the reagent. Both phagocyte populations reacted to soluble
aggregates of IgG and to the synovial fluid preparation, that
contained putative complexes. The soluble aggregate behaved
exactly as did the MxRF in that it produced an inhibition of
degranulation to HAGG in monocytes, but not in granulocytes
(Figures 8.9 and 8.10). The soluble aggregate was active only
— 1at a much higher concentration (500 yg ml )than was the MxRF 
-1(60 yg ml ) and even so was less effective (Figure 8.11).
This difference in effieciency parallels the finding that 
the inflammation properties of immune complexes depend very 
much upon their physical characteristics (e.g. Kavai et al.,
1981). Self-associated IgG/igM complexes such as might be 
present in the MxRF would thus be expected to react differently, 
and probably more specifically, with the cells than would the 
soluble aggregates. Kavai and her colleagues (1981) and Griffin 
(1980) have both demonstrated that soluble complexes inhibit 
monocyte/macrophage phagocytosis, and more effectively at 
equivalence or antibody excess. This seems to be mediated by 
blocking or selective ingestion of Fc receptors (Griffin, 1980). 
The ratio of antibody to antigen within the MxRF would be 
complicated by the fact that the IgG molecules could act as both 
while the IgM is antibody only. In addition, the complexes could 
bind to either, or both, y and p receptors on the monocyte.
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These experiments have shown that both MxRF and soluble 
aggregates are able to inhibit degranulation by monocytes and 
apparently by the same mechanism of reacting with the cells.
It is likely that they block Fc receptors that would otherwise 
react with the stimulus (Arend and Massoni, 1981; Kavai et al.,
1981) . Soluble immunoglobulin aggregates are taken up into 
lysosomes, so that exocytosis does not occur (Henson, 1977).
The same components were also able to cause superoxide 
release, but not inhibition of degranulation by PMN. Since 
these cells do not manifest IgM receptors (Henson, 1977), the
response to MxRF must be mediated through the Fc y portion.
The formation of rosettes with lightly opsonized erythrocytes 
has been reported to be inhibited by aggregated IgG, not only 
for monocytes but also for neutrophils (Scott C.S., 1979; Kavai 
et al., 1981). Binding to heavily sensitized molecules such as 
the particulate HAGG might be expected to be less easily 
inhibited. The Fey receptors on neutrophils have different 
characteristics from those on monocytes. For instance, they have 
a relatively low affinity for monomeric IgG as determined by 
inhibition of resetting, and unlike monocytes can react, albeit 
weakly, with unaggregated IgG4 (Scott C, 1979; Lawrence, Weigle 
and Spiegelberg, 1975) . They also require large amounts of 
particle-bound IgG'as a stimulus for ingestion when complement 
is absent (Ehlenberger and Nussenweig, 1976 and 1977).
Differences in affinities and concentrations of surface 
receptors are likely to be of the essence in a situation where 
response is so dependent upon a fine balance of the factors involved,
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CHAPTER 9 PERSPECTIVES
A number of experiments have been performed in order to study 
the characteristics of phagocytes from normal controls and from 
patients suffering from rheumatoid arthritis. These tests 
are presented in Figure 9.1 in which the important results are 
also included. On the left of the figure is the effect of serum, 
the measurement of Fc receptors and the manifold study of 
granulocytes with respect to degranulation and membrane stimulation 
(Chapters 5 and 8; Results 8.3 to 8.6 and Discussion 8.10). On 
the right, the reactivity of monocytes and granulocytes in the , 
presence of rheumatoid factors is presented.
It is interesting that the degranulation response of phago­
cytes is altered by the presence of serum whether it be human 
or bovine, fresh or inactivated for complement by heat or inulin 
treatment (Tables 6.1 and 6.2), and that this response appeared 
different in phagocytes from normals and from rheumatoid arthritis 
patients (Discussion 8.8). Which serum component is responsible 
for this behaviour is unknown and a search for it might provide 
some fascinating information on how granulocyte activity is 
regulated in vivo. It is also interesting to speculate whether 
the effect is upon 3-glucuronidase itself rather than on the 
cells. The activity of this enzyme can be decreased at low protein 
concentration, and more specifically by organic acids related to 
the tricarboxylic acid cycle and by ascorbic acid (Pearse, 1972). 
Although it seems unlikely that such inhibitors are involved, 
weight should be given to them and their significance tested out.
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Evaluation of the resetting behaviour of control and RA's PMN 
was carried out (see Chapter 7) and no difference in their Fc
Y
receptors could be demonstrated. The work laid out in Chapter 8 
provides evidence that their ability to be stimulated into producing 
reactive oxygen species is similar in both groups. Rheumatoid 
phagocytes appear to secrete slightly more sulphydryl-oxidizing 
molecules but marginally less superoxide and hydrolase-inactivating 
activity (which is probably hydrogen peroxide/myeloperoxidase 
mediated, Voetman et al., 1981).
The oxidation of serum thiol groups is thought to be mediated 
by hydroxyl radicals as well as by hydrogen peroxide (Hall and 
Blake, 1981) and the finding that this oxidation was slightly 
higher from patients* cells than from normals' neutrophils was 
in contrast to the significanct decrease in g-glucuronidase 
release. The events involved in the so-called metabolic burst 
are multifactorial (see for example Figure 1.2); it might be 
possible to discover whether one or more of the products could 
modulate membrane fluidity and phagosome-lysosome fusion. FOr 
instance, could the presence of larger than normal amounts of 
hydroxyl radical affect degranulation by neutrophils, and would 
the results of assays for this species correlate with g-glucuron­
idase release* OH promotes lipid peroxidation and so could damage 
lysosomal and plasma membranes (Lunec et al., 1981).
The transient life-span of such unstable molecules would 
seem to preclude their artificial addition to a phagocytic system.
As an alternative, a generating system such as xanthine plus 
xanthine oxidase could be employed (Rosen and Klebanoff, 197 9).
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It is,however, equivocal whether the effects of such an external 
source could be compared to a reaction that apparently occurs close 
to the invaginating membrane of a potential phagosome. The study 
of cells from patients with congenital abnormalities of leucocyte 
function (e.g. by Roos et al,, 1980) has been invaluable in 
exploratory work and would be necessary in order to validate these 
proposals.
The normal Fc receptors and near-normal membrane stimulation 
(oxygen-dependent anti-microbial systems) but abnormal g-glucuron- 
idase release raises the possibility that there is a lysosomal defect 
in the rheumatoid neturophils. Secondary lysosomes may not form 
as readily, so that a smaller proporti on of enzyme is released. 
Alternatively, they may close off lysosomes more readily in the 
situation of frustrated phagocytosis thcin do normal PMN, so that 
the measurable degranulation is less.
Degranulation is only one part of phagocytosis, and if a 
particle is small enough to be taken into a phagosome, exocytosis 
does not occur. Such complete ingestion may have taken place to 
some degree with the particulate aggregate, but it was not measured. 
Other workers have done so using IgG-coated latex and yeast, but 
the results have been conflicting in that they show either a 
decrease or no chdnge in PMN from rheumatoid arthritis patients 
in comparison to normals (Turner, Schumacher and Myers, 1973; 
Hallgren, Hakansson and Venge, 1978). It might be fruitful to 
measure, in separate assays, ingestion and degranulation of cells 
from the same blood sample. The relationship between the two
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could be positively or negatively correlated. If, on the other 
hand, both non-phagocytosable and phagocytosable stimuli were 
put together, the cellular behaviour might reflect the results 
obtained for monocytes with the mixture of rheumatoid factors.
It seems,therefore, that it would be reasonable to pursue these 
experiments further.
The total amount of g-glucuronidase within rheumatoid 
neutrophils is no different from that of normals (ovati observations, 
not shown; see also van de Stadt, van de Voorde-Vissers and 
Feltkamp-Vroom, 1980). It is conceivable that some 3-glucuron­
idase may already be trapped with previously endocytosed immune 
complexes and be unavailable for release. The experimental finding 
that inactivation may not occur on uptake of small molecules 
indicates that the latter could happen without a decrease in 
the total enzyme content of the cell.
It would seem sensible to histochemically stain fixed cell 
preparations for the presence of g-glucuronidase. A method which 
detects solely lysosomal g-glucuronidase uses as a substrate 
Naphthol AS BI glucuronide and stains the enzyme red (Pearse,
1972). Subsequent treatment with a fluorescein or peroxidase- 
linked anti-immunoglobulin would allow parallel detection of 
immune complexes,, Use of a horseradish peroxidase-linked 
"immunoperoxidase" method for detecting immunoglobulins could 
probably not be made because the brown deposits of its substrate 
could mask the red naphthol product mentioned above.
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It is important to consider whether or not this abnormality 
of degranulation is confined to rheumatoid arthritis or whether 
it is found in other chronic diseases such as systemic lupus 
erythematosus or juvenile rheumatoid arthritis. If it is found 
to be widespread, the defect may be directly related to the uptake 
of immune complexes by the cells in vivo . The need to measure 
intracellular complexes as well as phagocytosis has already been 
acknowledged (Chapter 5, Discussion), and this would be carried 
out in any further studies. The techniques of immunofluorescence 
or immunoperoxidase-conjugated antibodies could be used to 
demonstrate the binding of antisera to such complexes in fixed 
cells. A parallel measurement of fluid-phase immune complexes 
might allow correlation of the two. However, since the results 
of the numerous tests for immune complexes vary considerably 
(see for instance, Soothill, 1977; McCarthy et al., 1981; and 
Mumford, Horsfall and Maini, 1982), more than one would have to be 
carried out. The size of the complexes should be measured by, 
for instance, gel filtration or polyethyleneglycol precipitation, 
in addition to considering tlieir biological properties of binding 
rheumatoid factor and Fc receptors.
It seems unlikely that granulocytes that have been circulating 
freely in the blood would contain immune complexes; only those that 
have adhered to sites of deposition would be expected to have ingested 
them. This opinion is borne out by the observations that peri­
pheral blood PMN contain few or no inclusions as detected by 
immunofluorescence while larger numbers are found in those from 
synovial fluid to which the PMN have migrated in response to
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inflammatory stimuli (Vaughan et al., 1968; Cats, Lafeber and 
Klein, 1975).
It is hot known how many of the cells adherent to vessel 
walls become free-flowing again once they have ingested immune 
complexes, and what proportion of these are taken up by the 
mononuclear phagocyte system on their first circuit through 
the liver. Pertinent questions such as these need to be 
answered before the effect of immune complexes on the neutrophil 
population as a whole can be understood.
The degranulatory response of monocytes to particulate 
aggregated IgG is inhibited if soluble aggregates of IgG, or both 
IgM and IgG RF, are also present (Figures 6.1 and 8.10). The 
equivalent activity in granulocytes v;as not, however, affected 
(Figures 6.1 and 8.9) although both cell types were activated 
to release superoxide. Possible reasons for this difference 
have been discussed in the previous chapter (Chapter 8).
The estimation of enzyme release in the presence of two 
competing stimuli (i.e. at the same time) is hardly likely to 
be measuring the same process as exposure of a cell to a stimulus 
in vitro some hours after it has possibly phagocytosed in vivo.
An experiment in which phagocytes were pre-incubated in plasma 
containing immune complexes (from a patient with RA), followed 
only later by a challenge with aggregate, did indicate that 
ingestion of complexes could indeed decrease the degranulation 
activity of such cells (Figure 6.3). Unfortunately the tests
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were inconclusive and much more work needs to be done in this 
field.
The relevance of both IgM and IgG rheumatoid factors to 
inflammation has been considered (Chapter 1); are they protective 
or pathogenic? At the concentrations used, pure IgM RF appears to 
neither stimulate nor decrease the activity of phagocytes towards 
the aggregated IgG used in these experiments. Higher concentrations 
of IgM RF would have been used ha<3 more been available; it may 
have blocked the activity of neutrophils towards the stimulus, 
as it has been shown to do in published work (Ward and Zvaifler, 
1973b; Timms, Johnson and Henson, 1975), in effect by coating 
the stimulant with a protein for which the neutrophil has no 
receptor (IgM) (Henson, 1976). The effect of this preparation 
on monocyte degranulation is less predictable since IgM RF can 
bind to both aggregate and cell (see Discussion, Chapter 6).
The mixed IgM/IgG rheumatoid factor preparation, however, 
does block MNP degranulation and the close correlation between 
the inhibition by MxRF and soluble aggregates (Figure 8.11) 
suggests that the same process occurs. Like the soluble 
aggregates, the mixed-rheumatoid factor causes the release of 
free oxygen products that can alter molecules outside the 
cell (Lunec et ai,, 1981). An additional consideration is 
that monocytes, destined to become residents of the mononuclear 
phagocyte system, aremade refractory towards an immunoglobulin- 
stimulus vhen both types of rheumatoid factor are present. This 
could mean that they clear circulating immune complexes less
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well than if only IgM RF is present. In vivo therefore, this
associated IgM/IgG could be pathogenic or protective. The 
finding of Allen and colleagues (1981) that these complexes 
bind complement and at high levels are associated with systemic 
manifestations of RA suggests that they are harmful rather than 
helpful.
A preparation that consisted solely of IgG RF was not 
available for investigation; IgM RF is ubiquitous which makes 
purification difficult. It would have been interesting to compare 
the effects of IgG rheumatoid factor with those of other prepara­
tions. If, for instance, IgG RF proved only as effective as the 
soluble aggregates at inhibition, then one could postulate that 
it is the presence of IgM RF within the complex that is of paramount 
importance. This would, in addition, explain the lack of effect 
on the IgM-receptor negative granulocytes. Such experimental 
use of IgG RF is clearly required if the mechanism of action of 
these anti-inununoglobulin antibody complexes is to be understood.
In relation to this, artificially prepared complexes such 
as BSA/anti-BSA could be usefully employed. Not only might they 
affect monocytes as the MxRF has been shown to do, but also 
their uptake by granulocytes might induce a decreased responsive­
ness such as that*demonstrated for patients' cells.
The behaviour of rheumatoid arthritis patients' granulocytes 
was not apparently related to the administration of chemotherapy 
(Figures 5.3 to 5.5). This aspect could be investigated more
174
fully in patients who are not receiving any therapy, although 
this would be difficult. Alternatively normal volunteers could 
be 'treated' with a wide range of anti-inflammatory drugs for a 
longer period of time than that undertaken for the experiments 
represented in Figures 5.4 and 5.5. In addition to considering 
the effect of current treatment on laboratory tests, one should 
also take into account how therapy can be designed to bring 
those parameters back to normal in the hope that the clinical 
picture may improve. Biochemical improvements may precede those 
of the patient per se: for instance the levels of erythrocyte
glutathione (reduced form) can rise by 20 to 40% prior to any 
evidence of disease remission induced by D-penicillamine or 
aurothiomalate (Munthe, Kass and Jellum, 1981). In a wider 
context, it would seem that if a drug is to be effective in 
combating chronic inflammation it needs to efficiently block 
one or more pro-inflammatory reactions such as those described 
in association with Figures 1.4 and 1.5.
The biochemical studies in this thesis have shown a signi­
ficantly lower level of lysosomal enzyme secretion by rheumatoid 
neutrophils stimulated by particulate aggregated IgG,in 
comparison to their counterparts from normals. It is difficult 
to assess if the level of decrease found (for example 18.7 to 
13.9%, a 26% decrease, at 200 yg ml ^.HAGG), is clinically 
important. For instance, in a family which suffers from 
glutathione reductase deficiency, the heterozygous parents 
are healthy despite having lower than normal enzyme activity 
(Loos et al., 1976b; Roos et al., 1979). This situation is
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also true of Factor VIII deficiency (haemophilia) in which 
patients with plasma levels exceeding just 5% of the normal 
are only mildly affected (Mollison, 1979).
It is possible that the decreased enzyme release might 
produce a tendency for internalized pathogens to survive, and 
to replicate within the host cell. This occurs as part of the 
normal life-cycle of some viruses within macrophages (Morahan 
and Morse, 1979). The process of lysogeny with occasional 
reversion to virulence is well-known in prokaryotic hosts 
(Lewin, 1974), and occurrence of this within the granulocyte 
could aggravate the situation. The effects of chronic viral 
infection with reference to immune complex disease have 
already been discussed in Chapter 1, not least the local 
tissue damage and autoantibody production so characteristic 
of the enigmatic disease of rheumatoid arthritis.
Rheumatoid arthritis is a chronic inflammatory disease 
in which a number of aberrations are evident,and it is to be 
hoped that as each researcher adds his or her piece, the 



























_  H  M
i O  8fO 4J (0 
03 'd  05
c  c: o  H  
(d 0  -P A 0
PO 05 03 M
u  05 c: o







































































2 .  e n  2
p g  < — - > P  %
p PO P  PO
05 05 <T>
r—) 1—1
0 Z  0 05
M %  M P4
PO P PO P P
fd fd
< 0 <  0 •H
Pd ü K  O
177
I ara gazing
Into vAiat is man's foundation, the enduring scene that 
stands,
Comforted by sun and water, glad of either in their 
season,
Something that outlasts our minute, and has majesty for 
reason,
While its granites wear to sands.
Much I wonder.
Much I long for this to speak, for an Incarnate Scene 
to ccme
With a word for me to utter; so I ponder; so I hearken. 
Watching closely that I see it ere my fading eye-balls 
darken,
And repeat, ere I be dumb
All my knowledge.
All my being is summed up in this, the scene, that is a 
friend
That is comfort through the evil and the agony of living 
That, if heeding, and if judging, seems forgetting and 
forgiving 
And will seem so to the end.
Here I leave it.
Here it leaves me in the twilight, the imperfect wax it 
prest;
Knowing this, that it has shaped me, or mis-shaped me, 
for the telling
Of the purpose of the spirit that possesses this, in­
dwelling.
Knowing change, but never rest.
frcxn ‘The Hill' by John Masefield
Quoted with kind permission of The Society of Authors, as -the 
literary representatives of the estate of John Masefield.
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